S-8

As filed with the Securities and Exchange Commission on July 29, 2021

Registration No. 333-       

UNITED STATES

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

FORM S-8

REGISTRATION STATEMENT

UNDER

THE SECURITIES ACT OF 1933

Robinhood Markets, Inc.

(Exact name of registrant as specified in its charter)

Delaware	46-4364776
(State or other jurisdiction of incorporation or organization)	(I.R.S. Employer Identification No.)

85 Willow Road, Menlo Park, California 94025

(Address of principal executive offices, including zip code)

2020 Equity Incentive Plan

Amended and Restated 2013 Stock Plan

Restricted Stock Award Agreement

(Full title of the plans)

Vladimir Tenev

Co-Founder, Chief Executive Officer and President

Robinhood Markets, Inc.

85 Willow Road, Menlo Park, California 94025

(844) 428-5411

(Name, address and telephone number, including area code, of agent for service)

Copies to:

Andrew J. Pitts D. Scott Bennett Jonathan J. Katz Claudia J. Ricciardi Cravath, Swaine & Moore LLP 825 Eighth Avenue New York, New York 10019 (212) 474-1000 Daniel Gallagher Christina Y. Lai Weilyn Wood Steve Pickering Robinhood Markets, Inc. 85 Willow Road Menlo Park, California 94025 (844) 428-5411

Indicate by check mark whether the registrant is a large accelerated filer, an accelerated filer, a non-accelerated filer, a smaller reporting company, or an emerging growth company. See the definitions of “large accelerated filer,” “accelerated filer,” “smaller reporting company” and “emerging growth company” in Rule 12b-2 of the Exchange Act.

Large accelerated filer	o	Accelerated filer	o
Non-accelerated filer	x	Smaller reporting company	o
		Emerging growth company	x

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 7(a)(2)(B) of the Securities Act.  x

CALCULATION OF REGISTRATION FEE

Title of Securities to be Registered	Amount to be Registered(1)	Proposed Maximum Offering Price Per Share(5)	Proposed Maximum Aggregate Offering Price		Amount of Registration Fee
Class A common stock, par value $0.0001 per share:
—Shares issued pursuant to stock options and restricted stock units granted under the 2020 Equity Incentive Plan	5,591,024(2)	$38.00	$	212,458,912	$	23,179.27
—Shares issued pursuant to stock options and restricted stock units granted under the Amended and Restated 2013 Stock Plan	36,863,780(3)	$38.00	$	1,400,823,640	$	152,829.86
—Shares issued pursuant to the Restricted Stock Award Agreement	6,000(4)	$38.00	$	228,000	$	24.87
TOTAL:	42,460,804		$	1,613,510,552	$	176,034.00

(1)Pursuant to Rule 416(a) of the Securities Act of 1933, as amended (the “Securities Act”), this registration statement on Form S-8 (this “Registration Statement”) covers any additional shares of Class A common stock, par value $0.0001 per share (the “Class A common stock”) of Robinhood Markets, Inc. (the “Registrant”) that become issuable under the Registrant’s 2020 Equity Incentive Plan (the “2020 Plan”) and the Registrant’s Amended and Restated 2013 Stock Plan (the “2013 Plan”), by reason of any stock dividend, stock split, recapitalization or other similar transaction effected without the Registrant’s receipt of consideration which results in an increase in the number of the outstanding shares of Class A common stock.

(2)Represents (i) shares of Class A common stock issued in connection with the exercise of stock options under the 2020 Plan and (ii) shares of Class A common stock issued pursuant to the settlement of restricted stock units (“RSUs”) granted under the 2020 Plan.

(3)Represents (i) shares of Class A common stock issued in connection with the exercise of stock options under the 2013 Plan and (ii) shares of Class A common stock issued pursuant to the settlement of RSUs granted under the 2013 Plan.

(4)Represents shares of Class A common stock issued pursuant to a certain restricted stock award agreement, dated as of July 29, 2020 (the “Restricted Stock Award Agreement”).

(5)Estimated in accordance with Rule 457(h) of the Securities Act solely for the purpose of calculating the registration fee on the basis of $38.00 per share, which is the initial public offering price per share of Class A common stock as set forth in the Registrant’s Registration Statement on Form S-1 (File No. 333-257602), as amended, declared effective on July 28, 2021.

EXPLANATORY NOTE

This Registration Statement contains a “reoffer prospectus” prepared in accordance with Part I of Form S-3 (in accordance with Instruction C of the General Instructions to Form S-8). This reoffer prospectus may be used for reoffers and resales on a continuous or delayed basis of certain of those shares of Class A common stock of the Registrant referred to above that constitute “control securities” or “restricted securities,” within the meaning of the Securities Act, by certain stockholders that are current and former employees, consultants, and advisors of the registrant (the “Selling Stockholders”) for their own accounts. As specified in General Instruction C of Form S-8, the amount of securities to be reoffered or resold under the reoffer prospectus by each Selling Stockholder and any other person with whom he or she is acting in concert for the purpose of selling the Registrant’s securities, may not exceed, during any three-month period, the amount specified in Rule 144(e) under the Securities Act.

REOFFER PROSPECTUS

ROBINHOOD MARKETS, INC.

42,460,804 Shares of Class A Common Stock

___________________________

This prospectus relates to 42,460,804 shares (the “Shares”) of Class A common stock, par value $0.0001 per share (the “Class A common stock”), of Robinhood Markets, Inc. ( “Robinhood,” the “Company” or the “Registrant”), which may be offered from time to time by certain stockholders that are current or former employees, consultants, and advisors of the Registrant (the “Selling Stockholders”) for their own accounts. We will not receive any of the proceeds from the sale of Shares by the Selling Stockholders made hereunder. The Shares were acquired by the Selling Stockholders pursuant to our 2020 Equity Incentive Plan (the “2020 Plan”), the Amended and Restated 2013 Stock Plan (the “2013 Plan”) and that certain restricted stock award agreement, dated as of July 29, 2020 (the “Restricted Stock Unit Award Agreement”) .

The Selling Stockholders may sell the securities described in this prospectus in a number of different ways and at varying prices, including sales in the open market, sales in negotiated transactions and sales by a combination of these methods. The Selling Stockholders may sell any, all or none of the Shares and we do not know when or in what amount the Selling Stockholders may sell their Shares hereunder following the effective date of this Registration Statement. The price at which any of the Shares may be sold, and the commissions, if any, paid in connection with any such sale, are unknown and may vary from transaction to transaction. The Shares may be sold at the market price of the Class A common stock at the time of a sale, at prices relating to the market price over a period of time, or at prices negotiated with the buyers of Shares. The Shares may be sold through underwriters or dealers which the Selling Stockholders may select. If underwriters or dealers are used to sell the Shares, we will name them and describe their compensation in a prospectus supplement. We provide more information about how the Selling Stockholders may sell their Shares in the section titled “Plan of Distribution.” The Selling Stockholders will bear all sales commissions and similar expenses. Any other expenses incurred by us in connection with the registration and offering that are not borne by the Selling Stockholders will be borne by us.

Our Class A common stock has been approved for listing on the Nasdaq Global Select Market under the symbol “HOOD.” The initial public offering price of our Class A common stock pursuant to our Registration Statement on Form S-1, as amended (File No. 333-257602), declared effective on July 28, 2021, was $38.00 per share.

The amount of securities to be offered or resold under this reoffer prospectus by each Selling Stockholder or other person with whom he or she is acting in concert for the purpose of selling our securities, may not exceed, during any three month period, the amount specified in Rule 144(e) under the Securities Act of 1933, as amended (the “Securities Act”).

___________________________

Investing in our securities involves a high degree of risk. Before buying any securities, you should carefully read the discussion of the risks of investing in our securities in “Risk Factors” beginning on page 2 of this prospectus.

The Securities and Exchange Commission (the “SEC”) may take the view that, under certain circumstances, the Selling Stockholders and any broker-dealers or agents that participate with the Selling Stockholders in the distribution of the Shares may be deemed to be “underwriters” within the meaning of the Securities Act. Commissions, discounts or concessions received by any such broker-dealer or agent may be deemed to be underwriting commissions under the Securities Act. See the section titled “Plan of Distribution.”

Neither the SEC nor any state securities commission has approved or disapproved of these securities or determined if this prospectus is truthful or complete. Any representation to the contrary is a criminal offense.

___________________________

The date of this prospectus is July 29, 2021

TABLE OF CONTENTS

	Page
THE COMPANY	1
RISK FACTORS	2
SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS	3
USE OF PROCEEDS	5
SELLING STOCKHOLDERS	6
PLAN OF DISTRIBUTION	16
LEGAL MATTERS	18
EXPERTS	18
INFORMATION INCORPORATED BY REFERENCE	19
WHERE YOU CAN FIND MORE INFORMATION	20
PART I INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS	I-1
PART II INFORMATION REQUIRED IN REGISTRATION STATEMENT	II-2
EXHIBIT INDEX	II-4
SIGNATURES	1

___________________________

You should rely only on the information contained in this prospectus or in any accompanying prospectus supplement by us or on our behalf. We have not authorized any other person to provide you with different information. If anyone provides you with different or inconsistent information, you should not rely on it. We are not making an offer to sell these securities in any jurisdiction where the offer or sale is not permitted. You should assume the information appearing in this prospectus is accurate only as of the date on the front cover of this prospectus, regardless of the time of delivery of this prospectus or of any sale of the Shares. Our business, financial condition, results of operations and prospects may have changed since that date.

“Robinhood Markets, Inc.,” our logo, and other trademarks or trade names of Robinhood appearing in this prospectus are our property. This prospectus also contains trademarks and trade names of other companies, which are the property of their respective owners. Solely for convenience, trademarks and trade names referred to in this prospectus may appear without the ® or ™ symbols, but such references are not intended to indicate, in any way, that we will not assert, to the fullest extent under applicable law, our rights or the right of the applicable licensor to these trademarks and trade names.

Unless the context otherwise requires, we use the terms “we,” “us” and “our” in this prospectus to refer to Robinhood Markets, Inc. and its consolidated subsidiaries.

i

THE COMPANY

Robinhood Markets, Inc.

Our mission is to democratize finance for all.

Robinhood was founded on the belief that everyone should be welcome to participate in our financial system. We are creating a modern financial services platform for everyone, regardless of their wealth, income or background.

The stock market is widely recognized as one of the greatest wealth creators of the last century. But systemic barriers to investing, like expensive commissions, minimum balance requirements and complicated, jargon-filled paperwork, have dissuaded millions of people from feeling welcome or able to participate.

Robinhood has set out to change this. We use technology to deliver a new way for people to interact with the financial system. We believe investing should be familiar and welcoming, with simple design and intuitive interface, so that customers are empowered to achieve their goals. We started with a revolutionary, bold brand and design, and the Robinhood app now makes investing approachable for millions.

Our platform, which began as a U.S. stock-focused retail brokerage, currently offers:

•trading in U.S. listed stocks and Exchange Traded Funds, as well as related options and American Depositary Receipts;

•cryptocurrency trading through our subsidiary, Robinhood Crypto, LLC;

•fractional trading, which enables all of our customers—regardless of budget—to build a diversified portfolio and access stocks previously out of reach;

•recurring investments, which help customers make investing routine and employ dollar-cost averaging;

•Cash Management, which includes Robinhood-branded debit cards and enables customers to save and spend by paying bills, writing checks, earning interest, withdrawing funds via ATMs and receiving Federal Deposit Insurance Corporation pass-through insurance on cash swept from their brokerage account; and

•Robinhood Gold, our monthly paid subscription service that provides customers with premium features, such as enhanced instant access to deposits, professional research, Nasdaq Level II market data and, upon approval, access to margin investing.

Corporate Information

We were incorporated in the State of Delaware on November 22, 2013. Our principal executive offices are located at 85 Willow Road in Menlo Park, California 94025, and our telephone number at that address is (844) 428-5411. Our website address is www.robinhood.com. Information contained on our website is not incorporated by reference into this prospectus, and you should not consider it to be part of this prospectus.

1

RISK FACTORS

Investing in our Class A common stock involves risks. You should carefully consider the risks and uncertainties set forth under the caption “Risk Factors” in our Registration Statement on Form S-1, as amended (File No. 333-257602), filed with the SEC on July 27, 2021, which are incorporated by reference herein, and subsequent reports filed with the SEC, together with all of the other information contained or incorporated by reference in this prospectus, before deciding to invest in our Class A common stock. Our business, financial condition, results of operations and prospects could be materially and adversely affected by any of these risks or uncertainties. In that case, the trading price of our Class A common stock could decline, and you could lose all or part of your investment. Additional risks and uncertainties that we are unaware of or that we currently see as immaterial may also adversely affect our business.

2

SPECIAL NOTE REGARDING FORWARD-LOOKING STATEMENTS

This prospectus and the documents incorporated by reference herein contain forward-looking statements within the meaning of the federal securities laws, which statements involve substantial risks and uncertainties. Forward-looking statements generally relate to future events or our future financial or operating performance. In some cases, you can identify forward-looking statements because they contain words such as “may,” “will,” “should,” “expect,” “plan,” “anticipate,” “could,” “intend,” “target,” “project,” “contemplate,” “believe,” “estimate,” “predict,” “potential” or “continue” or the negative of these words or other similar terms or expressions that concern our expectations, strategy, plans or intentions. Forward-looking statements contained in this prospectus include statements about:

•our estimates of the size of our market opportunities;

•our ability to effectively manage our growth;

•our ability to successfully enter new markets, including any expansion into international markets, and comply with any applicable laws and regulations;

•our ability to invest in and develop our products and services to operate with changing technology;

•the expected benefits of our products to our customers and the impact of our products on our business;

•the effects of increased competition from our market competitors;

•the success of our marketing efforts and the ability to grow brand awareness and maintain, protect and enhance our brand;

•the impact of negative publicity on our brand and reputation;

•our ability to attract and retain our customers;

•our ability to maintain the security and availability of our platform;

•our ability to attract and retain key personnel and highly qualified personnel;

•our expectations regarding the impacts of accounting guidance;

•our expectations regarding litigation and regulatory proceedings;

•our expectations regarding share-based compensation;

•our ability to collect, store, share, disclose, transfer, receive, use and otherwise process customer information and other data, and compliance with laws, rules and regulations related to data privacy, protection and security;

•our ability to comply with modified or new laws and regulations applying to our business, and potential harm to our business as a result of those laws and regulations;

•the impact of adverse economic conditions;

•our expectations regarding the continuing impact of COVID-19 on our business;

•our expectations regarding the loss of our status as an emerging growth company; and

•the increased expenses associated with being a public company.

The forward-looking statements in this prospectus and the documents incorporated by reference herein are only predictions and are based largely on our current expectations and projections about future events and trends that we believe may affect our financial condition, results of operations, business strategy, short-term and long-term business operations and objectives, and financial needs. These forward-looking statements are subject to a number

3

of known and unknown risks, uncertainties and assumptions, including those described in the section titled “Risk Factors” and elsewhere in this prospectus and the documents incorporated by reference herein. Moreover, we operate in a very competitive and rapidly changing environment. New risks emerge from time to time. It is not possible for our management to predict all risks, nor can we assess the impact of all factors on our business or the extent to which any factor, or combination of factors, may cause actual results to differ materially from those contained in any forward-looking statements we may make. In light of these risks, uncertainties and assumptions, the future events and trends discussed in this prospectus may not occur and actual results could differ materially and adversely from those anticipated or implied in the forward-looking statements.

Because forward-looking statements are inherently subject to risks and uncertainties, some of which cannot be predicted or quantified, you should not rely upon these forward-looking statements as predictions of future events. The events and circumstances reflected in the forward-looking statements may not be achieved or occur. Although we believe that the expectations reflected in the forward-looking statements are reasonable, we cannot guarantee future results, performance or achievements. Moreover, the forward-looking statements made or incorporated by reference in this prospectus relate only to the events as of the date on which the statements are made. We undertake no obligation to update any of these forward-looking statements for any reason after the date of this prospectus or the documents incorporated by reference herein or to conform these statements to actual results or revised expectations, except as required by law.

You should read this prospectus, the documents incorporated herein and the documents that we reference in this prospectus and have filed with the SEC as exhibits to the Registration Statement of which this prospectus is a part with the understanding that our actual future results, performance, and events and circumstances may be materially different from what we expect.

4

USE OF PROCEEDS

We will not receive any of the proceeds from the sale of the Shares. All proceeds from the sale of the Shares will be for the account of the Selling Stockholders, as described below. See the sections titled “Selling Stockholders” and “Plan of Distribution” described below.

5

SELLING STOCKHOLDERS

The following table sets forth information with respect to beneficial ownership of our Class A common stock as of July 28, 2021, as adjusted to reflect the Shares that may be sold from time to time pursuant to this prospectus, for all Selling Stockholders, consisting of the individuals shown as having Shares listed in the column entitled “Class A Common Stock Being Offered.”

The number of shares beneficially owned by each stockholder is determined under rules of the SEC and includes voting or investment power with respect to securities. Under these rules, beneficial ownership includes any shares as to which the individual or entity has sole or shared voting power or investment power. Unless otherwise indicated below, to our knowledge, the persons and entities named in the table have sole voting and sole investment power with respect to all shares they beneficially owned as of July 28, 2021, subject to community property laws where applicable. In computing the number of shares beneficially owned by an individual or entity and the percentage ownership of that person, shares of our Class A common stock subject to options, warrants or other rights held by such person that are currently exercisable or will become exercisable within 60 days of July 28, 2021 are considered outstanding, although these shares are not considered outstanding for purposes of computing the percentage ownership of any other person.

We have based our calculation of the applicable percentage of beneficial ownership prior to this offering on 655,874,456 shares of our Class A common stock, 132,573,754 shares of our Class B common stock and no shares of our Class C common stock outstanding as of July 28, 2021, assuming:

•the automatic conversion, on a one-to-one basis, of all of our outstanding redeemable convertible preferred stock into shares of our Class A common stock, which will occur immediately prior to the completion of our initial public offering, as if such conversion had occurred on July 28, 2021;

•the automatic conversion of all of our outstanding Tranche I convertible notes, of which we had $2,601.4 million in aggregate amount as of July 28, 2021, including accrued interest, into 97,796,792 shares of our Class A common stock upon the completion of our initial public offering, based on a conversion price of $26.60 (which is the lower of (i) 70% of the initial public offering price of our Class A common stock of $38.00 per share and (ii) $38.29), as if such conversion had occurred on July 28, 2021;

•the automatic conversion of all of our outstanding Tranche II convertible notes, of which we had $$1,048.0 million  million in aggregate amount as of July 28, 2021, including accrued interest, into 39,397,201 shares of our Class A common stock upon the completion of our initial public offering, based on a conversion price of $26.60 (which is the lower of (i) 70% of the initial public offering price of our Class A common stock of $38.00 per share and (ii) $42.12), as if such conversion had occurred on July 28, 2021;

•the issuance of 2,829,445 shares of our Class A common stock and 199,652 shares of our Class B common stock upon the vesting and settlement of outstanding time-based restricted stock units (“RSUs”) for which both the time-based and the liquidity-based vesting condition was met in connection with our initial public offering (“IPO-Vesting Time-Based RSUs”), based on the number of IPO-Vesting Time-Based RSUs for which the time-based vesting condition was satisfied as of July 28, 2021, after withholding an aggregate of approximately 2,478,262 shares to satisfy the associated estimated income tax obligations (based on the initial public offering price of our Class A common stock of $38.00 per share and an assumed 45% tax withholding rate);

•the issuance of 2,218,856 shares of our Class B common stock upon the vesting and settlement of certain market-based RSUs that were granted to our co-founders under the 2013 Plan for which the market-based vesting conditions were satisfied in connection with our initial public offering (“IPO-Vesting Market-Based RSUs”), assuming the effectiveness of our initial public offering on July 28, 2021 for purposes of any applicable time-based vesting conditions and, for purposes of determining the satisfaction of the market-based vesting condition, the initial public offering price of our Class A common stock of

6

$38.00 per share, after withholding an aggregate of approximately 1,815,428 shares to satisfy the associated estimated income tax obligations (based on an assumed 45% tax withholding rate);

•the filing and effectiveness of our Charter in Delaware, which will occur immediately prior to the completion of our initial public offering and which will effect the reclassification of our common stock into Class A common stock;

•no exercise of outstanding warrants, of which $379.8 million aggregate maximum purchase amount was outstanding as of July 28, 2021 based on an exercise price of $26.60 (which is the lower of (i) 70% of the initial public offering price of our Class A common stock of $38.00 per share and (ii) $38.29);

•no exercise of other outstanding Company options, settlement of outstanding RSUs or conversion of our convertible notes except as described above; and

•that our founders elect to exchange all shares of Class A common stock initially received by them upon such vesting and settlement for an equivalent number of shares of Class B common stock pursuant to certain equity exchange rights.

We have based our calculation of the applicable percentage of beneficial ownership after this offering on 52,375,000 shares of our Class A common stock issued by us in our initial public offering, 2,625,000 shares of our Class A common stock sold by selling stockholders in our initial public offering, and 710,749,456 shares of our Class A common stock, 130,073,754 shares of our Class B common stock and no shares of our Class C common stock outstanding immediately after the completion of our initial public offering, giving effect to the foregoing assumptions and assuming that the underwriters will not exercise their option to purchase additional shares of' our Class A common stock from us in our initial public offering.

Unless otherwise indicated, the address of each beneficial owner listed below is c/o Robinhood Markets, Inc., 85 Willow Road, Menlo Park, California 94025.

	Class A Common Stock Beneficially Owned Prior to the Offering		Class A Common Stock Being Offered	Class A Common Stock Beneficially Owned  After the Offering(1)
Selling Stockholder	Shares	Percentage of Class	Shares	Shares	Percentage of Class
Aparna Chennapgragada	60,991(2)	*	60,991	—	*
Daniel Gallagher	350,442(3)	*	267,830	82,612	*
Gretchen Howard	682,155(4)	*	625,090	57,065	*
Christina Smedley	99,884(5)	*	99,884	—	*
Named Selling Stockholders(6)	56,409,826(7)	8.6%	41,407,009	15,002,817	2.1%

_______________

*Represents beneficial ownership of less than 1% of the outstanding shares of our common stock.

(1)Assumes that all of the Shares held by each Selling Stockholder and being offered under this prospectus are sold, and that no Selling Stockholder will acquire additional shares of Class A common stock before the completion of this offering.

(2)Consists of 60,991 shares of our Class A common stock issued upon net settlement of IPO-Vesting Time-Based RSUs.

(3)Consists of (i) 82,612 shares of our Class A common stock subject to stock options exercisable within 60 days of July 28, 2021 and (ii) 267,830 shares of our Class A common stock issued upon net settlement of IPO-Vesting Time-Based RSUs.

(4)Includes (i) 172,064 shares of our Class A common stock held by the Howard 2021 Family Trust, (ii) 57,065 shares of our Class A common stock subject to stock options exercisable within 60 days of July 28, 2021 and (iii) 419,300 shares of our Class A common stock issued upon net settlement of IPO-Vesting Time-Based RSUs.

7

(5)Consists of 99,884 shares of our Class A common stock issued upon net settlement of IPO-Vesting Time-Based RSUs.

(6)Includes the following 2,679 named non-affiliate selling stockholders:Alejandra Mendoza, Umnouy Ponsukcharoen, Uday Kumar Raju Ruddarraju, Perk Lun Lim, Pavan Piratla, Alexandra Bond, Hongjian Qi, Sahil Upadhyay, Zero Cho, Soh Yoon Ahn, Jerry Li, Shanthi Shanmugam, Daniel Hill, Youngjae Park, Lorraine Hammer, Jingyi Xue, Sam Lau, Christopher O'Neil, Abhishek Ray, Lee Byron, Deqing Chen, Lavinia Chirico, Amber Nuño, Shibo Zhang, Brandon Singh, Adele Faure, James Nguyen, Alison Wu, Jaren Glover, Marco Calderon, Qianyi Zhu, Chike Amajoyi, Yanlin Duan, Heng Wang, Evelyn Montiel, Nitin Narasimhan, Jonathan Chu, Henry Tay, Miles Wellesley, Samuel Kim, Abhishek Fatehpuria, Jayendra Jog, Sanyam Satia, Manuela Rios, Wander Rutgers, Curran Kaushik, Deen Adzemovic, Joseph Gillespie, Rundong Lyu, Nathan Ziebart, Ameya Khare, Weston Mizumoto, Jason Clavelli, Hongyi Li, Sahill Poddar, Jamshed Vesuna, Karen Shih, Arpan Shah, Hongxia Zhong, Brianna Bain, Mayank Agarwal and Sonal Dubey COMMUNITY PROPERTY WROS, Patrick Grossmann-Kavanagh, Nathan Yan, Oluwajare Fagbemi, David Cao, Joshua Hernandez, Stephen Chang, Xiaote Zhu, Kyle Matson, Kamran Malik, Daniel Chen, Thomas Linford, Onkur Sen, Eun Kyung Jeong, Mayank Agarwal, Nadezda Asoyan, Robert Thompson, Davina Boedijono, Amanda Drennan, Christine Brown, Jinyan Cao, John Reinstra, Peter Csiba, Ruby Wang, Xuewen Zhu, Yana Boubnova, Tristan Hayter, Robert Picard, David Nickels Jr, Felicia Kuznetsov, Jack Randall, Daniel Strizhevsky, Daniel Hsu, Smeeta Ramarathnam, Samuel Brin, Joseph Binney, Daesun Yim, Xuan Zhao, Bobo Li, Michael Machuca, Amy Shen, Joseph Zemek, Zoe Shewer, Gang Wu, Matthew Pearson, Zhuoying Wang, Jason Joyner, Divakar Vijayakumar, Shuo Xiang, Nathan Rodland, James Bator, Hao-Hsien Ko, Mengfei He, Brian Reisbeck, Josh Elman, Chun-Ho Hung, Charles Tennant, Neeraj Baid, Nicholas Benavides, Chuan Shi, Jing Wen, Cheung Kit So, Edmond Wong, Griselda Carlos Arzate, Lijia Hong, Calvin Luu, Yuxin Jin, Karthik Rangarajan, Chelsea Spinos, Marco Morales, Cosmin Gheorghe, Andrew Lee and Elizabeth Carter Su JT, Vineet Goel, Victoria Lai, Norases Vesdapunt, Zhemin Li, Noah Smith, Cody Goodermote, Caroline Brin, Brian Rowen, Max Bergen, Zane Bevan, Nathaniel Tucker, Sharon Huang, Nafeesa Remtilla, Sharadin Graham, Scott Kaczmarek, Yue Lu, Anne Ciccarelli, Shrey Kumar Shahi, Ralph Furmaniak, Alan Livshin, Tyrus Wilkins and Martha Christine Wilkins JT, Nigel Sussman, Ilie Ciorba, Stedman Wilson, Robert Cordes, Kathi Parsons, Monica Van Vleck, Meng Wu, Sunita Patradoon, Cynthia Owyoung, Marcia Cooper-Burrows, Sarah Sachs, Sherri Kacludis, Kayla Miller, Jonathan Azara, Rusudan Komakhidze, Melissa Wojcik, Richard Nuss, Joshua Steele, Anca Dulca, Margi Tucker, Xiaoxiao Fan, James Bahati, Laura Bones, Kirtan Mehta, Vikrant Goel, Ryan Tseng, Joshuah Touyz, Boney Sekh, Yao Li, Lisa Lam, Mitchell Bolin, Chi Zhang, TaNeika Francisco, Jenna Garden, Samuel Armstrong, Ryan Roubal, Sydney Young, Dennis Zhao, Vanessa Loya, William Patterson, Andy Smith, Patrick Keating, Viral Parekh, Tarimotimi Awipi, Hang Qian, Shane Hansen II, Kevin Stultz, Jeremy Moye, Chanel Summerset, Sheng Li, Yuan Lyu, Ryan Burns, Brian Zindell, Michael Conroy, Daniel Ortiz Rivas, David Straub, Xinlei Pan, Ryan Lewis, William Hu, Weston Gotuzzo, Genevieve Cruz, Monica Bobadilla, Fontaine Yuk, Cyrus Sarrafpour, Sofia Alvarado, Shivam Sarodia, Kenysha Felix, Hilary Kunz, Adrien Truong, Jason Lucibello, Angela Tucker, Lionel D'adesky, Marisa Thein, Matthew Etheridge, Pepe Nava, Felipe Estrada, Dylan Waters, Alexander Mastando, Tammy Halawi, David Flagg, Jerome Atkinson, Matthew Philabaun, Aaron Weiss, Douglas Miller, Richard Reitzfeld, Francisco Cano, Jonathan Brennan, Carly Dalbey, Douglas Hindman, Bulat Bazarbayev, Casey Becker, Francis Choi, Cody Koelzer, Daniel Simmons, Jason Graham, Ashley Csencsits, Brandon Tanguay, Jaspal Basra, Anthony Medina, Joseph Mortenson, William Irwin, Nili Moghaddam, Katelin Dilger, Yong Woo Rhee, Denzel Singletary, Robert MacGilvray, Kathryn Clabby, Andrew Yeung, Bernardo Leal, Paul Duan, Alex Beech, Kathryn Holmes, Gilbert Saunders, Kesav Mulakaluri, Jose Ulloa, Jared Edwards, Scott Batley, Madhukiran Muthukumar, Caleb Sima, Elizabeth Kran, Allum Ross, Sebastian Morales, David Wilson, Yukun Gao, Brooke Wendell, Natasha Fredrickson, Daniel Chung, Thomas Yu, Monika Hutchinson, Brian Blick, Connie Schan, Jesper Johansson, Grant Sander, Carly Moore, Robert Velez, Oliver Lead, John Bourdeau, Anthony Cao, Yara Akiki, Elijah Verdoorn, Lynn Chyi, Lillian Yamada, Brendan Byrne, Khalena Muslem, Mervyn Bradley Haw, Donovan Espree, Chad Hicks, Parasto Shamlou, Derrick Ho, Vidit Drolia, Samuel Chapman, Scott Young, Daniel Turner, Erica McCormick, Daniel Manata, Yuhao Zheng, Andrea D'Eramo, Kathryn Wallace, Andrew Reed, Guangchen Chen, Emanuel Mazzilli, Josue Pasarell, Brianna Watterson, William Galvin III, Wendy Qian, Xuan Zhang, Alexander Shaffer, Pooja Anand, Ashley Lancaster, Austin Garcia, Amy Liu, Minh Le, Denver Louis, Song Wang, Akhila Bhoopalam, Jingbo Jiang, Daimon Greaves, Katharin Powers, Christopher Hill, John Drake, Chen Cheng, Mario Cediel, Surabhi Gupta, Jeremiah Leeper, John Olson, Nivetha Purusothaman, Keyan Zhang, Colin Seale, Mack Colen, Brett Bingham, Eric Wolfman, Frank Sanford, Kimberly Hranicky, Olaolu Adedoyin, Juan Saa Gutierrez, Benjamin Leder, Matt McDermott, Bryanna Vanenburg, Joynesha Battle,

8

Jacob Austin, John Pantin, Azeem Khalid-Segraves, Chuyue Ming, Kennedy Stumpf, Patrick Moody, Mack McCain, John Hoard, Scot Galvin, Ryan Quevedo, John Newkirk, Steve Pickering, Ashley Tang, Nicholas Dellamaggiore, Xinyu Zhang, Britnee Marshall, Bradley King, Stephanie Jefferis, Nahyua Mu?iz, John Turner, Brian Taylor, Jill Perks, Ryan Ragona, Lisa Newkirk, Mercedes Escandon, Steven Alvarez, Tremaine Tasher, Cade Flory, Anthony Diveglia, Bobbek Hakimzadeh, Zibo Gong, Taeshima White, Andrew Goodman, Jonathan Howell, Amrita Shah, Cecilia Ng, Vishal Parikh, Brianna Anderson, Amy Jennison, Dustin Meade, Reyna Valdez Serrano, Karin Ostrander, Quentin Lafontaine, Remy Virin, Piotr Filipiuk, Renjie Zhu, Alex Chang, Edward Lian, William Kenny, Christopher Knox, Fengchen Guo, Christopher Clarke, Jarred Tompkins, Sunny Yu Yeung Chan, Bo Teng, Alyssa Junk, Christopher Hart, Jin Yang, Micheal Harpe, Daniel Bringle, LaSalle Vaughn, Meng Dong, Pablo Rodriguez Pacheco, Adam Vanek, Shawn Vanschoonhoven, Nicholas Lin, Jie Cai, Tessa Bryant, Angela Hung, Jennifer Hsu, David Jones, Kristin Ardourel, Andrew Lee, Weisi Duan, Guangyu Zhang, Matthew Carroll, Matthew Brownlee, Aarati Soman, Stuart Olivera, Kiefer Hurst, Wesley Strickland, Kevin Khaw, Tiffany Soebijantoro, Wei Sun, Travis Bowie, Marina Berhosky, Mananki Parulekar, Dana Mitri, Ugur Yildirim, Joaquin Coria, Elexis Palmer, Wes Vallentine, Kevin Jimenez, Richard Brightman, Yun Chi, Harrison Pollock, Charlie Pisuraj, Cris Partidas, Jaime Beaman, Flora Somogyi, Kevin Spinosa, Marcus Rulloda, Janet Ng, Alan Spivey, Sadie Braxton, Alvin Dacenay, Brandon Glass, Anna Gasparyan, Brandon Beach, Michael Pompeo, Chandra Kuchi, Paula Desmond, Joseph Carbone, Blake Transano, Lefei Zhang, Andrew Tower, Kunal Bisla, Philip Morris, Buckinson Levasseur, Matthew Ferro, Luis Ceja, Christian Young, Brandon Stout, Brandon Ramirez, Elizabeth Reasch, Inna VanMatre, Priyesh Patel, Austin Randall, Alina Cheng, Sean Yoo, David Bruder, Donald Onejeme, Emmanuel Masona, Jacqueline Baker, Devin Skolnick, Gabriel Gurau, Jared Eskenazi, Daniel Zayas, Ruhan Wang, Ijeoma Emeagwali, Simone Garreau, John Cukierski, Lonnie Lester, Judith Garb, Davi Augusto Caetano de Jesus, Aashna Aashna, Kelly Zigaitis, LeRahn Murray, Robert Knox, Kristy Briggs, Yue Li, Samantha Kattalia, Luis Zapata, Martin Fiemawhle, Soumya Kalra, Laurent Linville, Erica Crosland, Ngan My Tran, Ashley Baker, Balaji Varadarajan, Christopher Gruendel, Pui Lam Lee, Spencer Janyk, Ryan Muise, Charles Beck, Polina Morozov, Hui Lu, Shen Jin, Brian Francis, Joe Zhao, Nicholas Miller, Muthiah M Muthaia Chettiar, Andrew Brenner, Keith Kelley, Michael Bailey, Grace Qi, Michael Bailey, Valerie Kocsis, Dylan Norton, Serena Rizzo, David Ezeibeamadi, Erica Almonte-Wiggins, Kylie O'Connor, Brian Myers, Cesar Colon Rivera, Richard Frank, Abdul Syed, Sean Wallace, Joshua Powell, Teri Agricola, Sodbileg Bolor, Brandon Webb, Victor Bravo, Jessica Price, Cameron Rogowski, Xin Xia, Scott Porteous, Ishita Shah, Amogh Vasekar, Shaan Appel, Ashley Santiago, Miriam Hertz, Calvin Liang, Karen Pan, Alan Aisbitt, Gina Baker, Kurt Meyers, Marcel Perry, Christian Rubio, Ryan Joslin, Stephan Zharkov, Stephanie Macias, Esther Layode, Alison Malamud, Breana Fish, Thomas Nelson, Sylvia Chaudoir, Aaron Luu, Sami Mansur, Taylor Scanlon, Caroline Wong, Changyuan Liu-Navarro, JoAnna Martin, Matthew Schumann, Eric Prusinski, Antonique Foster, Amir Homayounfar, Kelly Panagon, Kimberly Hsiao, Carley Olivas, Zachary Diaz, Andy Le, Henry Liu, David Junker, Daniel Liu, Troy Delaney, Aihua Peng, Mercedes Hauck, Joann Chang, Aaron Walker, Michael Aldrich, Boyang Dun, Honghao Zhang, Charles Davidson, Jacob Roth, Stephanie Pogoda, Shannon Maharajh, Imelda Romero, Shawn Olsen, Yue Cao, Christian Legnitto, Shan Lu, Brenna Monahan, Daniel Belay, Yasmine Briedj, Clemens Buehling, Alexander Keefe, Tiffany Siu, Audrey McNay, Jaimeson Smith, Kyle Marston, Justin Hauck, Chao Chen, Tobian Wong, Midelene Pierre Fils, Jessica Denton, Ian MacGilvray, Eric Castro, Avneet Behniwal, Laverne Kuo, Bernard Boulos, David Stephens, Chase Smith, Jack Qian, Allyssa Peterson, Shelly DeVries, Sheira Sarfaty, Tianhao Wang, Jainin Shah, James Harnar, Rodly Cazy, Bryce Dupree, Haley Fisher, Yijie Feng, Prashant Nadagoud, Prashant Kumar, Ryan Tite, Scott Shultz, Christopher Martinez, Ashley Rich, Gary Shen, Renata Paulino Policicio, Junchen Zhang, Charles Peterson, Aminaaz Jaffer, Leigha Jackson, Evan Brooke, Afnan Arif Abdullah Binshikhan Al Yafaey, Ellen Luo, Joshua Rosenfeld, Joshua Hall, Leiann Nuzum, Alexandra Betrone-Harpst, Ian Levesque, Christopher Grant, Joshua Rountree, Scott Trotter, Heather Breslow, William Reich, David Verdin, Joseph Hoard, Simon Beyene, Joana Nguyen, Janette Herrera, Siyu Chen, Leon Nansaram, Kristen Lange, Nicholas Dotson, Rachel McClintock, Melissa Branch, Chandrabh Akireddy, Ken Langlinais, Francis Miles, Binyomin Einstein, Puneet Kumar, Chase McQueen, Kevin Wyatt, Jonathan Toung, Daniel Johnson, Andrew Arifin, Zachary Greene, Alexandra Kiner, Nazanin Arandi, Andrew Jordan, Alexander Thomas, John Karas, Emily Foster, Katelyn Drakos, Sylvie Brillaud, Zeyuan Jin, Yvette Ferrari, Matthew Utley, Shawn Mooring, Sharmaine Eugenio, Julian Williams, Anthony Armada, Jeremiah Torbit, Amitabh Sural, Rumana Patel, Tiffany Chen, Yebin Tao, James McCorriston, Ariel Horowitz, Ayan Siddiqui, Eugene Shapiro, Savitri Acharya, Jasmine Hanley, Gabriela Gonzalez, Brendan Goodwin, William Gray, James McElhannon, Paul Wilson, Adam Fine, Yibin Lin, Mingzhu Liu, Scott Chou, Jenny Lam, Oluwabukunmi Ayanbule, Allie Kind, Noel Lamb, Heather Peterson, Justin Kelly, Robert Salvador, Matthew Mersman, Zachary Bartlett, Alissa Dominguez, Amber Rymer, Zhicheng Wen, Jay Pandya, Jenny Prior,

9

Sheree Lee, Philip Balikowski, Robert Coleman, Natalia Kanevsky, Nathan Fox, Catherynn Vuong, Michael Fretwell, Michael Sternberg, Andrew Busker, Joshua Demeke, Vasantha Nandi, Pavel Tenenbaum, Jacqueline White, Paul Armstrong, Xianrui Meng, Maxwell Carpenter, Tanvi Motwani, Yi Ren, Corey Harris, Valerie Zavitsanos, Adam Wolf, David Michael McFarlane, Britten Michalik, Shawn Strong, Anton Bohomol, Jennifer Hammond, Samantha Davison, Sarah Prather, Chelsea Marie Fuerte, Peter Tamburo, Amelia Goldberg, Constance Lam, Adithya Shricharan Srinivasa Rao, Ben Rindels, Andrew Fry, Jizhou Fu, Daniel Kozlowski, Alyssa Knox, Warren Harvey, Robert Spickler, Matthew Gantz, Cody Dawkins, John Louie, Tianyi Wang, Christopher Werker, Robert Tressler, Jamie Leatham, Junlin Liu, Andre Hafner, Matthew Cleto, Timothy Brenden, Tatiana Pena, John Parker, Jackson Reid, Nikolai Hristov, Jimmy Fang, Jasmine Rhodes, Dong Chen, Michael Dennis, Otto Santos, Jorge Londono, Martin Umpierrez Icaza, Sophie Allen, Conria D'Souza, Paul Stanley, Xavier Rashotsky, Emily Hinger, Chester Mcgowan, Jura Bogomolov, Daniel Peterson, Mathangi Sankaran, Archit Shah, Yen-Ting Liu, Molly McDaniel, Daniel Claytor, Perry Elizabeth Wong Costa, Alexander Lee, Alexis Munger, David Moss, Ifigenia Pedretti, Isaiah Haynes, Ryan Beach, Benjamin Jiang, Kayla Yuen, Xinsui Zhang, Brady Shi, Aaron Lancaster, Karima Osman, Sabrina Hand, Noah Tseng, Zhaohua Zeng, Yunjia Xu, Anjana Guliani, Tyler Goltl, Olivia Barreras, Chase Patterson, Christine Jue, Martin Garcia, Andres Riverway, John Ramsey, Kaylee Marohl, Zachary Porter, Joshua Carpenter, Sandeep Koppala, Chenyu Yan, Melissa McCann, Sidney Muse, Steve Lusietto III, Oluwayaymisi Noni Marks, Santiago Buenahora, Daniel Ha, Gabriella Castillo, Minh Vo, Abhishek Shivanna, Erika Balbuena, Steven Ross, Noah Zahnd, Abbey Abate, Akash Ramani, Jacob Wondolowski, Quinton Ranzau, Paolo Cruz, Giovanni Campanale, Tyler Wall, Tevita Tapavalu, Eric Igberaese, Peng Yuan, Nathan Teale, Sandy Zanaty, Regina DeNatale, Xier Zheng, Charles Young, Cyrus-Charles Weaver, Denise Burgos, Lindsay Morrison, Rigoberto Marquez, Andre An, Savannah Schultz, Ryan Gordanier, Marc Hernried, Edson Vargas, Moisey Khaimov, Carl Oehmig, Takeem Mitchell, Phillip Vasquez, Jiabei Xu, Michael Hauser, Gabriel Benmergui, James Wang, Adrian Cruz, Dawit Aboye, Avery Waldera, Abraham Sandoval, Xiao Wen, Qihui Xu, Moises Urrutia, Krishna Santosh Reddy Suravaram, Saraj Munjal, Vincent Forand, Michael Eisendrath, Cody Taylor, Kelsey Emmert, Frederick Dannen III, Pratikbhai Patel, Xiandong Ren, Joalma Holland, Bradley Groth, Amir El-Baghdady, Vanessa Castrillo, Nicholas Sharp, Riddhi Shah, Andrew Burks, Ciera Logan, Ryland Thomas Carter, Keegan Connor, Katherine Sotiroff, Sharise Harrison, James Herriotts, Mitch Atkinson, Jacquetta Woods, Jace Hartley, Radu Marin, Muhammad Ahmad, Joseph Hahm, Yan Yan, Jasmine Baliwag, Alkin Sen, Bryan Hang, Taylor Brown, Chinyere Atufunwa, Priscilla Bence, Kelechi Dike, Cornelle Hehmann, Vartika Jain, Tao Huang, Christopher Hahne, Juan Gutierrez, Junhui Zhang, Alfonso Pozo-Gutierrez, Lauren Hinkle, Tori Brackens, Mark Rietveld, Jae Hyeon Bae, Benjamin Fogler, Curtis Carnahan, Pearce Wray, Duy Nguyen, Eric Appel, Samantha Lee, Beth Bailen, Sivaramakrishnan Subramanian, Christine Hung, Jemal Osejo Santana, Crystal Sims, Tahlese Wright, Scott Hershorin, Vincent Widjaya, Hannah Primm, Oscar Rodrigo Roldan, Haitong Li, Francoise Finance, Emmerly Khounlo, Lauren Ottinger, Cynthia Mao, Songlin Li, William Bogle, Yue Shi, Aaron Khan, Teddy Dulca, Jesse Faggioli, Mark Murphy, Dino Piazza, Juan Rodriguez, David Long, Grace Boatwright, Grecia Liliana Chavez Alvarez, Cynthia Oam, Nicholas Tulenko, Donald Gatewood, Nathan Leung, Preston Bordelon, Raul Lucero Luevano, Terra Prince, Chad Johnson, Hannarae Annie Nam, William Yoshimura, Kristian Tran, Kenneth Jacobs Jr, Seok Lee, Chloe Kurzon, Hector Hurtado, Hanna Neisz, Hayley Bierbaum, Yajaira Roldan, Mark Berger, Yuchen Jiang, Brennan Reinert Jr, Bart Tissue, Lianghui Li, Ashley Hulting, Marc Helou, Vandita Bakore, Anupriya Ghate, Kathleen Chaykowski, Mireille Delbecq, Gabriel Del Rio, Raechel Kimbriel, Jeffrey Dillard, Bianca Dahlen, Ryan Kelley, James Coulter, Kevin Dagostino, Gianni Bessette, Jakob Hochberg, Nicholas Reina, Johann Kerbrat, Ben Ellenbogen, James Armstrong, Sammar Edstrom, Brandon Burtner, Rachel Momperousse, Henry Roach, Callum Powers, Megan Propst, Mahdi Raza, Yomna Hawas, Paul Marshall, Devon Ashbridge, Preston Walchli, Philip Yates, Thejaswi Kadur, David Vennefron, Vasavi Bollaram, Sebastian Novelo, Harry Sanabria, Jacob Osterman, Lorianne Woldehanna, Austin McKinley, Michael Luksich, Michael Lepore, Krystal Tillman, Diana Tunon, Ernesto Ortega, Joshua Snyder, Rohit Ranjan, Kamal Ramchandani, Brian Tate, Jun Yoon, Daniel Fuchs, Charles Gavlak, Brandon Campbell, Gemma Horn, Eric Ragland, Meredith Lyons, Dongliang XU, David Dusseault, Lucas McLean, Jena Bennett, Samuel Begley, Jessica Carter, Nabeha Brown, Andrew Nemetz, Tushar Bansal, Sriram Bhargav Karnati, Jennifer Aguilar, Zitong Li, Stephanie Stevenson, Yaning Yu, Munish Bhatnagar, Trang Huynh, Anna Radyvonyuk, Matthew Monius, Qian Mu, Sara Ali, Moyuan Huang, Dorian Leyva, Mitchell Thunell, Anne Novikov, Tony Fu, Tiffany Chung, James Tan, Abigail Robinson, Ali Janmohammad, Rhys Williams, David Favreau, Marisabel Fernandez, Esther Fialho, Rhonda Sims, Allen Bevans, Kyle Kinsey, Raymond Zheng, Fuad Elfar, Kizel Lewis, Shawn Jordan, Huy Vo, Parker Godkin, Tyler Hines, Jai Srivastav, John Roman, Matthew Carter, Michele Soanes, Laci Davis, Lauren Zaroukian, John McMahan, Ayan Bandyopadhyay, Matthew Denney, Christopher Garcia, Margaux Lee, Claire Chiu, Dawei Zhao, Aza Dargalaye, Aravind Rao,

10

Amy Enamorado, Gurpreet Suri, Bhavishyavani Ravi, Kelly Hoppensteadt, Cristopher Crisologo, Xiaoyong Zhou, Ian Johnson, Amanda McBride, Ada Ruzer, Cameron Kopplinger, Melody Zanaty, Andreea Goncearenco, Baogang Song, Rushikesh Deshpande, Bryan Jung, Geoffrey George, Will Danuser, Chelsea Oertel, Chinsin Sim, John Brereton, Fernando Morales, Christina Kapadia, Virginia Brake, Dao Han Lim, Lisa Robinson, Colin Umbarger, John Greer, Dina Finkilshteyn, John Hill, Geoffrey Gaudoin, Dexter Smiley, Mohammed Jaffer, Laurel Hilbert, Alvin Lee, Rachel Depew, Patricio Pereyra, Nizam'Alam Fatani, Henry Wong, Kelley Davidson, Xin Hu, Andrew Walsh, Richard Jackson, Ashley Smith, Tiera Jackson, Alexa Nordic, Cameron McLenaghan, Zachary Shelden, Pratiksha Rakesh Singh, Esther Lin, Matthew Goss, Nick Castellano, Gabriel Silk, Joseph Wong, Lindsey Holt, Dijohn Mckinney, Arthur James Shello, Scott Friedman, Elizabeth Yeh, Alyssa Clang, Uday Patil, Heather Wellman, Joanna Denison, Marnie Flynn, Cathy Liu, James Marecle, Annie Herlitz, Sophia Huard, Swaroon Sridhar, Carlo Callwood, Kevin Le, Togan Gencoglu, Elizabeth Osborn, James Baxendale, Bhupendra Ubeja, James Ginn, Brendan Davis, Rebecca Moretti, Ibrahim Nabhan, Kisalaya Prasad, Peyton Collins, Michelle Piwowarski, Sofia Young, Jeffrey Seto, Brian Jackson, Matthew Tatham, Nan Yin, Paul Davis, Jisung Kim, Shiv Verma, Wenting Xi, Nicholas Wilson, Jason Hall, Chabula Mulumbu, Tanya Smith, Kelly Cruz, Michelle Chen, Xuandong Lei, Chenheng Liu, Garrett Crissman, Benjamin Grauel, Barbara Flathers, Mantas Matelis, Eric Hains, Paula Loop, Thomas Floyd, Cassandra Kjorness, Jingru Ren, Rich Bessel, Matthew Yorkavich, Auster Chen, Albi Mema, Lauren Cahill, Kate Mapstone, Jeffrey Giuffrida, Garrett Minton, Samuel Yau, Tealee Hinger, Michael Obucina, Nathan Hernandez, Hunter Cowper, Austin Geraghty, Nicole Wright, Zachery Crane, Noah Madover, Andrew Hsu, Uday Anand, Alex Mesa, Samantha Haertl, Jose Sanchez, Chelsy Alexander, Natalia Wojtowicz, Matthew Hunter, Krishna Behara, Idaraobong Ikafia, Brielle Filtch, Venkata Krishna Pavan Kalubandi, Jennifer Henion, Raymond Poloncic, Duy Vo, John Priest, Navya Mayyadi Pedemane, Edward Rossman, Michael Dalton, Alexander Vladimirov, Audra McKay, Christopher Kienle, Kayla Jackson, Keenan Fultz, Sandeep Kaur, Vishal Kuo, Matthew Kellie, Tianze Hu, Catherine Most, Mi Hua, Lauren Hollett-Mott, Justin Kelly, Jonty Fox, Julia Borello, Kyla Samad, Jalyn Isley, Alexander Batoon, Kelly Harvell, Cherlyn Medina, Arth Acharya, Bryan Cathey, Hugo Larrazabal, Maria Cobb, Brandon Ellerby, Yvana Pham, Briana Richardson, Arpitha Nandakumar Kashyap, Alexandra Methot, Ian Samms, Caleb DeLaet, Katherine Creamer, Braedon Martinez, Alexander Masbruch, Tarique Rubab, Zhanat Abylkassym, John Sims Jr., John Lyons, Sierra Molina, Jessica Chang, Ann Rajan, Samantha Klonaris, Stephanie Vazquez, Amanda Amat, Gerlishia Bracy, Britney Hamlin, Riley O'Neil, Taylor Davis, Collin Irwin, Suraj Jagadeesh, Jennifer Losier, Aaron Smith, Tanner Freeman, Megan Ferris, Philip Chang, Herman Guillen, Renee Motley, Wren Wegner, Amy Yang, Martha Sandra Cabatic, Blake Williams, Christopher Olenik, Frank Valles III, Jun Helzer, Lauren Van Cavage, Benjamin Rosamond, Eunhye Suh, Ilan Goodman, Bethany Hamilton, Jisu Yoo, Xu Tjhin, Bradley Wong, Jenna Morris, Michelle Hurst, Sujith Katakam, Beau Burton, Eric Heden, Bailey Landrum, Eduardo Gaitan, Amelia Moreno, Ryhan Otmane-Tani, Maria Katrina Munez, Nicholas Gottfred, Benjamin Holt, Elyce Ladany, Kyra Sopinka, Weilyn Wood, Valeriana Wisniewski Budilov, Sophia Dutra, Leah Evans, Patrick Diomede, Jason Lu, Ryan Maddux, Nosa Alonge, Jingyi Huang, Jake Weintraub, Everett Barney, Tawny Labrum, Hali Reedy, Zachary Woolford, Itzael Vargas, Alexa DeGroat, John Hawkins, Xi Zheng, Jonathan Johannemann, Andrew Wagner, Derrick Haggard, Chase Crighton, Scott Dishnow, Rocir Marcos Leite Santiago, Brenton Bade, Doran Rivera, Alexis Bernstein, Mitchell Kager, Matthew Thompson, Quiana Davis, Kevin Sorensen, Jack Forrest, Eileen Dai, Amanda Enters, Mark Wolff, Raj Solanki, Kevin J Schillo, Alesa Roti, Yunfan Feng, Rebecca Sheridan, John McCay, Brandon White, Sarah Harley, Sakhi Gandhi, David Neisz, Zachary Johnson, Ian Kitts, Hailey Williams, LaRosa Osborne, Marcos Juarez Lopez, Yufei Wang, Thoufique Haq, Varun Mohan, Kristin Dixon, Tyler Yep, Alexander Eagle, Nicholas Ciuffo, Jonathan Meador, Melissa Rush, Jayden Rolstone-Kobal, John Cahill, Vikram Sharma, Pooja Arondekar, Jessica Salvesen, Nanxi Liu, Nicholas Miller, Kamini Ortiz, Ryan Hickey, Jennifer Walker, Andrew Truong, Grant Bradford, Bradley Hall, Hao Chang, Gabrielle Eliason, Avani Sharma, Anthony Cavallaro, Sangita Bajpai, Matthew Starr, Adam Wagner, Matthew Jordan, Tiffany Citra, Yuchen Jiang, Christopher Yturralde, Rinkal Agrawal, Annie Longley, Sophie Manoukian, Jeffrey Weiss, Katelyn Harrison, Sabrina Espinoza, Robert Luna, Nancy Sarokhan, Destry Garcia, Kyle Winters, George Garcia-Serra, Inha Joo, Eric Black, Matthew Sousa, Sean McGowan, Rongrong Yang, Bethany Zorc, Angela Perkinson, Kwesi Nketia, Nan Wang, Janice Kwong, Benjamin Fox, Nurym Kudaibergen, Joshua Dutill, Hannah Ginsburg, Joseph Barreras, Garret Frank, Jocelyn Yap, Neeharika Komma, Alisa Young, Lucas Moskowitz, Connor Howell, Isidro Perez, Kunal Desai, Lindsey Graetz, Andrew Cheek, Nathan Odeh, Garret Kelly, Yevgeniy Pushin, Elaine Lin, Thery Prok, Timothy Dolquist, Gavin Hagestad, Elliott Forde, Dominique Cotto, Caesar Gamulja, Abon Chaudhuri, Marc O'Such, Matthew Scott, Tyrone Croutch, Scott Racusin, James Swartwout, Shruti Batra, Mary Westberg, Lindsey Henry, Bradford Strickland, Trevor Beckwith, Shannon Bridgeman, Sarah Hill, Burton Wheatlake, Eric Noel, Wenlong Xiong, John Allen, Georgios Takos, Kaitlyn Vinson, Laurence Gross,

11

Matthew Argomaniz, Ariel Chait, Guillermo Injoque, Samantha Pritchard, Jamie Emerson, Mohamed El-Ghoroury, Hongtai Li, Jasmine Yi, Nicholas Williams, Morgan Chow, Anushree Rajendra Jain, Kevin Jacobs, Maria Pimenova, Ilya Izrailevsky, Margaret Ketchum, Abraham Zamudio, Brian Zimmerman, Alvin Vicioso, Stacie Schwartz, Ryan Fitzgerald, Rana Bahri, Rob Balian, Marcelo Modica, Jianda Zhou, Rafael Resende Jr, James Hunt, LaRae Sanchez, Oliver O'Neal, Morgan Fields, Aaliyah Phillips, John-Carlos Rivera, Yuchen Li, Kevin Yeung, Mandar Samant, Lucia Pradas-Bergnes, Luke Scriffiny, Taylor Jacob, Terrence Ho, Anthony Barbato, Alan Van Dorn, Chloe Bierman, Hemal Doshi, Dat Tran, Di Chen, Chandler Mercer, Ivan Zhou, Erik Leff, Colin Dickens, Aman Singh, Dheerja Kaur, Nicholas Reid, Connor Coleman, Won-Woo Chung, Marc Barnett, Dennis Lafferty, Anne DeSantis, Mabruk Bessiouni, Olliver Joseph, Joseph Iraci, Zainab Akande, Fangqi Zhao, Gongzhan Xie, Anthony Liggins, Joshua Love, Johanna Phu, Zachary Petersen, Althea Dunn, MingPeng Chen, Tyler Davlin, Juan Roa Echeverria, Paul Berger, Ximena Keirouz, Dolly Ye, Nora Chan, Tiffany Booth, Yvette Zayas, Shiyi Zhao, Dunyuan Chen, Savanna Foster, Heaba Shishani, Tyler Pruitt, Nicole Evans, Zhimin Zong, Mehdi Taifi, Eric Carlson, Husain Talawala, Katie Van Loo, Evelyn Yonaki, Devin Malone, Brian Etheridge, Mac Liu, Cory Howard, Ekaterina Presnetsova, Ema Milojkovic, Yeounoh Chung, Irvin Sha, Daniel Zou, Jiaxi Kang, Holly Livolsi, Linda Som, Daniel Cronin, Artemis Brown, Dominic Bunch, Oluwatobi Oluwo, Brian Tao, John Markle, Anthony Aviles, Paul Lewenberg, Adam McCarthy, Alec Richter, Hyewon Lee, Rama Alebouyeh, Pinal Shah, Katherine White, Patrick Devlin, Eric Lovett, Taylor Osborn, Christopher Dangerfield, Cody Hooten, Ya Yu, Chad Butler, Gina Rollings, Alexandra Toribio-Cruzado, Rachel Mastro, Yi Chen Cao, Brooks Taylor, Chloe Kennedy, Amanda Do, Michael Holmes, Dylan Jones, Aaron Moreton, Julia Setnicker, Andrew Davis, Michael Smith, Christopher Boggs, Christopher Merrill, Dennis McDaid, Monica Jin, Joyce Park, Srivatsan Sridharan, Nathaniel Moore, Joshua Drobnyk, Mitchell Colen, Jared Gray, Loni Bogenschutz, Shahmeer Navid, Emily Carlson, Megh Mehta, Evan Kenebrew, Emilee Peavler, Courtney May, Matthew Depew, Joanne Chai, Jean Bredeche, Crystal Gilbertson, Ulises Rojas-Sandoval, Jade Van Horn, Aayush Tyagi, Seyed Hossein Kaffash Bokharaei, Paul Radulovic, Louis Finley, Taylor Wingard, Yunong Jiang, David Aghassi, Daniel Shepherd, Aries Vazquez, Renjini Ramesh, Richard Dana, Jorge Tirado Tolosa, Benjamin Miller, Evans Smalley, Kan Ta, Aaron Barstad, Daniel Ziegler, Christopher Gates, Henry Foster, Tiffany Arrington, Reno Mathews, Kevin Acala, William Haltmar, Boyang An, Kathryn Kitchell, Ricardo Bravo, Melina Iacovou, Christopher Owen, Amanda Fitz, Christopher Chalek, Lee Rodriguez Mercado, Laura Rushing, Alvin Hui, Corinne Cuddeback, Kaegan Crayton, Michael Lambard, Lawrence Johnson, James Loat, Noah Adams, Mun Yong Jang, Jeremy Lieber, Junrui Hu, Bjoern Eivind Rostad, Casey Baker, Randall Purdy, Yemin Shou, Bohan Ren, Harneet Kaur, Taylor Mann, Patrick Dunn, Christian Theilemann, John Parker Kelliher, Bret Wade, Robert Ballance, Kyle McCann, Victoria Nguyen, Adam Lessen, Michael Headrick, Monika Qualls, Queenie Ma, Thomas Elliott, Amanda Cendejas, Shaherzad Azim, Michael Snowden, Kahlela Mungin, Ronald Ding, Phillip Langston, John Hellweg, Yuzhang Wu, Michael Morell, Yuyang Xie, Phyo Kyaw, Thomas Krohn, Connor Brockmeier, Milena Milojicic, Amy Shan, Nolan Ray, Bhavesh Viswanath, Michael Bush, Carston Cook, Aparna Verma, Richard Mulvihill, Jessica Koehler, John Jones II, Jay Sridharan, Galinda Marquez, Kenneth Ton, Jade Buchmyer, Viyat Bhalodia, Keyra Galvan, Tennessee Lee, Desiree Brewer, Tatum Thornton, Alexandra Nagy, Javonte Duncan, Natee Tesfa, Vanesa Huang, Christopher Grajales, Louie Rosales, Yang Xiao, Eric Deacon, Mitchell Burke, Daniel Odom, Khin Phong, Weimin Ma, Jose Ortiz, Abigail Brown, John Steigerwald, Miles Mobley, Hanna Lee, Mukaddes Dreischhoff, Louis Vetter, Imogen Morris, Kyle Considder, Lucy Ijatomi, Zezhou Liu, Stephanie Selvius, Abraham Chong, Claudia Del Rio, Jenna Shorten, Anthony Gentry, Mazin Bokhari, Zhenting Huang, Christian Mladenov, Riley Wood, Erik Bush, Guillermo Gallegos, Sarah Mort, Olivia Cheung, Devin Sullivan, Erin Ward, Turner Albertson, Kaustubh Rudrawar, Atit Doctor, Cody Liversedge, Thorvald Bean, Erin Weno, Fiona Naughton, Stephen Colgan, Vigneshwer Vaidyanathan, Alix Davie, Zun Wang, John Black, Vina Uriarte, Kelly Miller, Jeremy Croston, Kristina Delgado, Austin Bach, Varun Gurnaney, Xiaoyu Fang, John Gebhardt, Philip Wettersten, Jinshan Jia, Christopher Duroseau, Chirantan Mahipal, Piret Loone, Travis Nichols, William Diskin, Symone Chavez, Britt Clark, Milton Patrick, James Amurao, Evan Nolan, Christopher Artnak, Brittany Frescoln, Nathan Navasca, Dawn Pagliaro, Maxwell Sidebotham, Michael Landau, Bhavya Bharat Agarwal, Haley Lit, Xiaoyu Chen, Robert Gonzalez, Saibra Rubadue, Joe Letchford, Simoul Alva, Yan Sun, Li-Fan Yu, Mehdi Aourir, Jung Yeon Ryu, Christina Lai, Adrian Bilotti, Devin Smith, Brady Cooper, ChenGuang Dong, Brian Lin, Drake Sichak, Marina Canova, Brooke Ichinose, Wen Bin Wu, Andrew Coleman, Thomas Kushnerick, Wenbiao Xing, Michael Quilatan, Luke Willets, Joel Hull, Rahul Sihag, Arvind Raghavan, Jordan Frasse, Dai Jun Tang, Jessica Clouse, Aaron Ko, Aubrey DeBose, Vamsee Yarlagadda, Tamara Bain, Adam Gorelick, Noreen Juliano, Whitney Anderson, Allen Ma, Peisen Zhao, Cara Bain, Muhammad Hussein, Cheyenne Knueppel, Corey Perrigo, Ramon Salvador, Dallas Brignone, Boris Epstein, William Hendricks, Elliott Wells, Jennifer Howard, Radha Krishna Kollipara, Dana Hawkins, Arthur Murdock, Joseph Wells, Dean Mincer,

12

Nicolas Martell, Yang Liu, Stephanie Truong, Dylan Walters, Nicholas Pita, Christopher Lawson, Sherwin Li, Peter Stephenson, Vibhav Kotriwala, Sierra Stein, Ahmed Zahran, Joshua Cockrell, Rachel Pharazyn, Shanshan Zhu, Peng Liu, David Ellis, Nicole Bartel, Jordan Meaux, Joscaly Hodge, Diana Laguna, Christopher Wong, Aloke Fernandes, Adam Sassatelli, Yuliya Foerster, Rachel Maples, Matthew Rosario, Michael Hunter, Paul Tarjan, Johnny Nguyen, Qihao Xie, Alexander Brown, Murat Ogul, Devon Reese, Victor Bivol, Tianyue Xiao, Fay Vlahu Scott, Wilson Turner, Kasen Quiring, Robert Chappell, Ben Beatty, Jacqueline Ortiz Ramsay, Simon Herran, Reneze Trim, Shuai Sun, Tyler Mathis, Alexandre Farran, Jonathan Stockton, Joseph Nichols, Jairo Henao, Charlotte Keeler, Qiyao Qin, William Richardson, Betty Zhao, Jorge Cepeda, Shuotian Cheng, Daniel Bolin, Benjamin Dunn, Kyle Polley, Sheila Masley, Siddharth Patel, William McEachern IV, Emily Anding, Zhengguang Chen, Giselle Rivera-Davila, Edwin Rodriguez, Alexandra Vorrasi, Amy Liang, Michelle Brewster, Christian Horn, Nathan Palmer, Keun Park, Karthik Kenchaiah, Chen-Hung Wu, Nicholas Olson, Jacob Martin, Seong Seog Lee, Joshua Martin, Zhuosheng Jiang, Can Wang, Vincent Maccariello, Annie Yu, Justin Lu, Megan Lowecki, Tiffany Clark, Kyle Melkert, Tess Singha, Kristin Brown, Samuel Lopez Cuevas, Jiahe Xiao, Cody Scott, Carrie Brown-Coats, Nicole Ostertag, Krystyna Tuchkova, Divya Mathew, Xin Yu Yuan, Patrick Southern, Jonah Torrison, John Cosbey-Lewis, Byron Wilson, Michael Tom, Cody Ipock, Holly Shirmenzagas, Silvestras Visockas, James Layton, Ishaan Parikh, Tanaya Joshi, Michael O'Toole, Mitchell Salers, Ziyou Zheng, Jessica Woods, Jhoselyne Canales, Robert Malone, Guillermo Ramirez, Alix Claude, Brooke Norton, Mark Buckingham, Julia Cadena, Wicky Dharani, Joseph Song, Francois Benjamin, Justin Bell, Diana Ramirez, Brandon Tucker, Mihaela Ciocanu, Jacob Schwartz, Timothy Kallander, Brian Denny, Robert Eller, Owen Mellick, Connor Carion, Quanlai Li, Jeffrey Lee, Anna Chernov, Nicole Nelson, Brian Hines, Jonathan Rubinstein, Noman Goheer, Yue Ding, Suvrat Rao, Kyle Black, Jennifer Daemon, David Jolly, Patrick Howell, Lori Meacham, Neil LaVigne, Jose Albiter, Radha Modi, Jensen Meaux, Victorino Chavarria, Jared Nowak, Ruirong Yang, Amanda Magyar, Xuying Zhu, Travis Shimizu, Rebecca Kruse, Jeffrey Hood, Sabrina Ali, Dennis Leverette Jr., McKenna Granger, Nguyet Tran, Andres Ruiz, Ashley Berger, Alexander Cheney, Sachin Gupta, Tejaswi Venugopal, Nigel Mills, Kelsey Parker, Wai Chip Ngai, Nicholas McElroy, Samuel Thompson, Yinyi Wang, George Shell III, Richard Cho, Philip Rykyto, Jarrett Butler, Tyson Lersch, Ask Hoel, Cayce Martin, Andrew Godwin, Jamie DeCrescenzo, Rena Park, Renata Menezes, Mohamed Ewumi, Debbie Croasdaile, Bethany Kwitek, Anthony Lawrence, Stephanie Zau, Qing Li, Christina Diaz, Christopher Fahy, Erik Drygas, Charris Wells, Leslie Simonson, Ashley Velasquez, Krista Fryauff, Yoojung Jung, Marcellus Pelcher, Devon Lloyd, Omar Rayward, Ziqiang Yu, Shiho Sakai, Vy Mai, Thomas McGinn, Caroline Harris, Clayton Halim, Jamaly Farquharson, Brandon Laiche, Cristian Vega Valadez, John Ricklefs, Rachel Haigh, Russell Lifson, Thayrine Rodrigues Downing, Andrew Chen, Molly Sundeen, Camilo Aldana, Carleen Liu, Elijah Pandolfo, Chelsea Krogwold, Ivy Murphy, Stanley Kwong, Roukyatou Diallo, Kelsey Dunn, Averill Snyder, Eleanor Newcomb, Giselle Martinez Flores, Mengyi Li, Shana Terry, Albert Choi, Kelsey Yee, Michael De Gaglia, Steijn Pelle, Mingkang Zhang, Victoria Thompson, Kristina Petersen, Stephon Angry, Adarsh Pandiri, Pio DiBenedetto, Deborah Beene, Robert Lipps, Lucy Yip, Carina Pappu, Caitlyn Crawley, David Vigano, Michael Heath, Christine Williams, Julia Dranov, Joseph Barrett, Sang Su Lee, Michael Vernon, Yu Xie, Huanjun Bao, Ella Corey, Yen-Ming Lee, Matthew Edwards, Mike Yoffa, Mohit Bhura, Kyle Walsleben, Indira Pal, Kevin Chin, William Keeth, Amry Kimmerly, Amandeep Sheena, Stephanie Dempster, Nourhan Nasser, Rashad Drakeford, Mai Nguyen, David Keyser, Apoorva Iyer, Derrick Routier, Morgan Levine, Solace Shen, Maxim Rabiciuc, Anne Milliken, Charlene Delapena, Sonali Upadhye, Chantal De Soto, Swathi Chandrasekar, Paridhi Khaitan, Gregory Crane, Youngeun Hyun, Cody Meyers, Celeste Ewing, Jaylon Briggs, Rob Carman, Tatiana Denisova, Annamarie Gamez, Andrew Peng, Zixu Zhu, Geoffrey Boss, Adam Harris, Cody Drummond, Timothy Trautman, Ronnie Higgs, Shelley Carella, Jennifer Hollenkamp, Tanner Owens, Avery Peterson, Trevor Healy, Cuisheng Yao, Andrew Wright, Collin Emmert, Erik Buckman, Kerry Underwood, Pieter Weyns, Craig Barrere, Eugene Shen, Jiawei An, Amanda Higgins, Ahmad Fulwood, Jiawei Zhang, Callie Reber, Thomas Beattie, Abby Fournier, Jacob Letzring, Lindsay Koprivica, Jordan Garside, Susan Terenzio, Katrina Gamutan, Brandon Velasquez, George Wright, Richard Myers, Sagar Agarwal, Margot Valenzuela, Syrina Rice, Ikai Lan, Conrad Verkler, Zhi Zhang, Craig Reyes, Andrew Mulhall, John Beaty, Tian Zhang, Jeane Ferdinand Carlos, Aniket Mandalik, Carolyn Kao, Tara Meilinger, Alexander Chiou, Diana Hernandez, Daniel Mahoney, Rachel Marie Reyes, Jonathan Barrett, Hector Arellano, John Castelly, Bahrom Akramov, Ryan Kofron, Pierce Edwards, Cody Marshall, Patrick Fahey, Brandon Sterling, Anthony Centeno Torres, George Tong, Victor Regalado, Omid Scheybani, Lisa Murray, Ilana Black, Xiaohang Liu, Joshua Weaver, Sean Kennedy, Eli Arzhevskiy, Colin Reisterer, Bhupesh Bansal, Matthew Reilley, Matthew De Silva, Simeon Schopf, Shannon Rowell, Jediah Powers, Jose Garcia, David Dalton, Jean Carlo Sanclemente, Qingjun Zhang, Nathan Chou, Steven Lysenko, Megan Finch, Samuel Yanez, Carina Cater, Maria Wood, Tyler Todd, Prenston Perry, Daniel Haire, Ethan Behnke, Ryan Williams, Angelica Davis,

13

Jeffrey Meyers, John Kramer, James Cruz-Youll, Bradley Olson, Leon Love, Shray Pungaliya, Justin Farmer, Katherine Burke, Jessica Shu, Danielle Lavigne, Depei Zhang, Bryanna Mundy, Kevin King, Shriram Gharpure, Evan Dawson, Wouter Massa, Rachel Fletcher, Mary Elizabeth Taylor, Mihika Poddar, Jacob Shattuck, Joseph Bianco, Caroline Langner, Jeremy Leu, Mark Dye, Zihan Ban, Matthew Miller, Camilo Ossa, Norman Ashkenas, Kwan-I Lee, Krystelle Buenafe, Adam Wolff, Rashim Khadka, Shulin Yang, Randal Howell, Myles Baker, Syed Kumail Naqvi, Chengyin Liu, Stacy Johnson, Giti Baghban, Sang Won Suh, Desiree Caballero, Sam Nordstrom, Michelle Dawson, Andrea Wright-Macedo, Lorenzo Pavia, Shubhi Badjatiya, Mayur Saxena, Jordan Lanthier, Rasarag Sarsam, Kendra Doty, Robert Zoellick, Alicia Phan, Jonathan Chiou, Christopher Munn, Desiree Choy, Gunner Pinkerton, Melody Tackitt, Bianca Walters, Ping Chan Lin, Maxwell Taylor, Michael Longstreet, Samantha Chieng, Emily Marie Mares, Itzel Carreon Tapia, Teddy Ni, Kevin Yin, Charlie Martell, Teddy Doodnauth, Annie Mandell, Malik Manogin, Akshay Jain, Berott Mathnov, Ian Young, Kyle Podgurski, Tyler Whitten, Chia-Huei Lo, Courtney Dunbar, Robert Guzman, Lauren Gibson, Ali Algarmi, Christopher Saloman, Chen Chen, Oliwia Szczerbowska, Danielle Owusu, Siddharth Vartak, Devonte Snowden, Lauren Resende, Candice O'Hara, Jerry Tsui, Anthony Taranto, Rosalie Kim, Dan Feldstein, David Nicponski, Alexis Jean, Joshua Indykiewicz, Eric Ngo, George Escandon, Carlos Acosta Moncada, Allan Liu, Michael Sherron, Nimit Agrawal, Jeffrey Lee, Christian Zwicky, Bradley Schlagel, Bruce Martin, Sy-yang Na, Caleb Luckett, Dylan Lindimore, Matthew Strope, Archana Matela, Dana Kaplan, Melissa Kincaid, Marcella Cindy Prasetio, Matthew Cunningham, Danielle DiCoscia, Daniel Ramirez, Matthew Hingst, Calum McWhir, Agung Atmaja, Joseph Grundfest, Michael Bueno, Brandon Land, Micah Rouse, Turmunkh Zorigt, Dhruv Rajan, Katherine Abbott, Simon Shulman, Kari Mertz, Garrett Holden, Andrew Rimmer, Ashleah Yzaguirre, Chu Ngo, Crystal Haka, Walter Carroll, Rebekah Bourque, James Kong, Aaron Shequen, Helen Zhang, Melissa Lester, Loren Sexton, Kiley Rourke, Alexander Katz, Eleanor Trinh, Woradorn Kamolpornwijit, Ankit Katiyar, Ricardo Duenas, Asad Rana, Michael Kornegay, Chris Mahan, Michael Bouchier, Connor Nagelvoort, John Reese, Lisa Boss, Nalina Bergman, Daniel Mitchell, Chelsea Goodfellow, Abdullah Hashmi, Lei Gao, William Lipplett, Eric Pond, Tyler Livermont, Ian Tejeda, Jennifer Scheck, Brian Haberly, Christopher Flannery, Abdiel Rivas, Rida Safdar, Aaron Pimienta, Daniel Himmelstein, Thomas Grey III, Vladimir Tikhonov, Harshini Kalpesh Shah, Damian Wieczorek, Allan Reyes, Ying Wang, Arami Reyes, Dustin Beaver, Carrie Rivers, Joyce Ehrlinger, Erin Merchant, Kelly Zhang, Jeffery Abbott, Cindy Aguilera, Mark Kohl, David Applegate, Raza Rasheed, Maria Rosca, Luis Brahm-Smart, Krishna Sunil Yekasi, Nicholas Winant, Tracy Firmin, Staci Smith, Erin Todus, Diana Mazo, Adia Brown, Muema Lombe, Graham Roth, William Butler, Wanqian Zhou, Golbanoo Naghshineh, Yuan Liu, Edward Morris, Lily Wang, Ryan Jensen, Thushara Mudireddy, Jeffrey Hobble, Jessica Robson, Heidy Hernandez Breton, Sunny Sang, Kerry Schmidt, Josiah Bales, Rajeev Krithivasan, Ryan Cook, Ashley Wong, Brian Dzou, Michael Jensen, Beatriz Santiesteban Horta, Jill Stoever, Kamal Boparai, Cal Singleton, Erika Dean, Stephanie Wallin, Stephanie Garcia, Shannon Amin, Cole Mitchell, Justin Maher, Dominique Doan, Tuan Anh Dau, Stephanie Rabinowitz, Qichen Gao, Dante Bouldin, Thant Htoo Zaw, Haley House, Christopher Weaver, Aaron Henry, Isaiah Wright-Wiggins, Di Liu, Garrett Phillips, Bryan Velasco, Creston Stickels Jr, Matthew Greenhalgh, Louis Fernandez, Blake Martin, Hannah O'Toole, Destinee Gutierrez, Hye Won Lee, Zona Pan, Scott Shields, Gilles Mischler, James Molina, Lauren Pettinato, Justin Bynum, Rob Wang, Clint Edwards, Anthony Link, Savannah Smart, Christopher Harrison, Jacob Conway, David Glynn, Tongbo Luo, Monica Philip, Holly Miller, Joseph Burgess, Taelor Fair, Kevin Jin, Daniel Kelati, DeAnna Caggiano, Jialiang Wang, Brad Hesla, Siyu Liu, Caitlin Boyle, Nolan Bland, Taylor Evans, Ryan McCaffrey, Lindsay Perez, Haotian Xu, Shan He, Jason Dewn, Yifan Li, Jonathan Quinteros, Valeria Hurtado-Lopez, Noah Lazaro, Melisa Fich, Mahim Patel, Jerrell Taylor, Srikanth Devidi, Bryant Obeng, Joel Knight, Jake DeBellis, Kevin Serwatka, Christopher Tassone, Addie Ford, Javier Oviedo, Jin Gong, Svetoslava Slavova, Binxiang Ni, David Paley, Gabriella Garcia, Yuyang Zhang, Trisha Patel, Nicholas Zurick, Jing Wang, Mark Gillean, Greg Pstrucha, Cecilia Chen, Brian Pipkin, Shana Green, Benjamin Parks, Tsz Choi Lau, Madeline Schnipper, Mohamed El Fellah, Mohammad Fathi, Rex Dendinger, Edward Myles, Akshay Udiavar, Ye Liu, Brian Correro, Dawei Deng, Nicholas Luisi, Rachel Shern Mae Leong, Jennifer Chen, Jonathan Fersh, Josue Calvillo, Jose Michel, Gustavo Marquez, Ann Bergquist, Robert Choe, Hal Anderson, Wenxu Mao, Qingqing Zhang, Christopher Rapp, Christa Tallman, Jason Lyons, Jeffrey Tribble, Craig Pinkston, Chase Turnage, Matt Dusseault, Kathleen Robinson, Ranier Lopez, Desiree Desai, Anthony Onochie, Tara Vishnesky, Jeffrey Wang, Robin Soto, Siddharth Bidasaria, Chloe Barz, Monica Murray, Vikram Atre, Li Zhang, Tami Davis, Selam Kidane, Deanna Shears, Lauren Faltys, Jordan Campbell, Camila Hernandez Bojorquez, Hamna Nazir, Weiqi Cai, Boyang Tian, Iwona Wakuluk, Richard Wood, Chadwick Albert, John Fawcett, Joyce Lee, Debleena Roy, Kendall Messmer, Leslie Rojas, Puneeth Gadangi, Calli Singleton, Sreeram Ramji, Ayse Erkan, Gabriela Trio, Yizhou Ye, Priscilla Hernandez, Ozan Demirlioglu, Gavin Duke, Saige Xie, Tyler Duignan, Santiago Murillo, Robert Ewing, Eric Charway, Ninya Beyer, Diana Fu, Osasumwen

14

Obaizamomwan, Lauren Remson, Congnan Zheng, Steven Hanson, Sul Ah Seo, Cory Pruce, Jordan Schroeder, Sara Rush, Heather Greening, Jose Maceda, Michelle Gard, Yichuan Huang, Christine Reyes, Patrick LeFevre, Dustin Wilhelm, Strongpoint Holdings LLC, Kamran Malik and Shafaq Latif JT, The Friedman Family Revocable Trust, The Nicole K Friedman Family Trust, SIF IRREVOCABLE TRUST, NKF IRREVOCABLE TRUST, Michael Patrick Milliken and Anne Hoge Milliken, Co-Trustees of the Milliken Family Trust u/a/d 11/11/2005, KJCY Resources, LLC, FMB Resources, LLC, FAD Resources, LLC, KCJ Resources, LLC, Nadezda Asoyan and Paul Asoyan TENCOM, Max T Bergen and Sarah Azizi COMMUNITY PROPERTY WROS, Gottipati Aravind, Barcenas Christian, Scott Kaczmarek and Abigail Perri Barnes TENCOM, David Nickels and Jeff Lutman COMMUNITY PROPERTY WROS, Sara D. Friedman Irrevocable Trust, Niko G. Friedman Irrevocable Trust, Howard 2021 Family Trust, The Ray Investment Trust, Anne Ciccarelli and Sabrina Ciccarelli TENCOM, Heather Elizabeth Breslow and Andrew Breslow TENCOM, Stephen Chang and Lisa Guo TENCOM, Eun Kyung Jeong and Jihoon Kim TENCOM, Davina Boedijono and Edmund Loo TENCOM, Peter Csiba and Katarina Csiba Sabova TENCOM, Nicholas James Dellamaggiore and Catherine Marie Dellamaggiore TENCOM, Zane Bevan and Lisa Preville COMMUNITY PROPERTY WROS, Mitchell Burbick, Dave Babulak, Jeffrey Currier, AnYuan Guo, Michael Liou, Andrew Myers, Andrew Ondrak, Jeffrey Feinglas, and Michael Rauchman. Each of these persons or entities beneficially owns less than 1% of our Class A common stock.

(7)Includes (i) 15,002,817 shares of our Class A common stock subject to stock options exercisable within 60 days of July 28, 2021 and (ii) 11,472,654 shares of our Class A common stock issued upon net settlement of IPO-Vesting Time-Based RSUs (based on an assumed 22% tax withholding rate).

15

PLAN OF DISTRIBUTION

We are registering the Shares covered by this prospectus to permit the Selling Stockholders to conduct public secondary trading of these Shares from time to time after the date of this prospectus. We will not receive any of the proceeds of the sale of the Shares offered by this prospectus. The aggregate proceeds to the Selling Stockholders from the sale of the Shares will be the purchase price of the Shares less any discounts and commissions. We will not pay any brokers’ or underwriters’ discounts and commissions in connection with the registration and sale of the Shares covered by this prospectus. The Selling Stockholders reserve the right to accept and, together with their respective agents, to reject, any proposed purchases of Shares to be made directly or through agents.

The Shares offered by this prospectus may be sold from time to time to purchasers:

•directly by the Selling Stockholders, or

•through underwriters, broker-dealers or agents, who may receive compensation in the form of discounts, commissions or agent’s commissions from the Selling Stockholders or the purchasers of the Shares.

Any underwriters, broker-dealers or agents who participate in the sale or distribution of the Shares may be deemed to be “underwriters” within the meaning of the Securities Act. As a result, any discounts, commissions or concessions received by any such broker-dealer or agents who are deemed to be underwriters will be deemed to be underwriting discounts and commissions under the Securities Act. Underwriters are subject to the prospectus delivery requirements of the Securities Act and may be subject to certain statutory liabilities under the Securities Act and the Exchange Act. We will make copies of this prospectus available to the Selling Stockholders for the purpose of satisfying the prospectus delivery requirements of the Securities Act. To our knowledge, there are currently no plans, arrangements or understandings between the Selling Stockholders and any underwriter, broker-dealer or agent regarding the sale of the Shares by the Selling Stockholders.

The Shares may be sold in one or more transactions at:

•fixed prices;

•prevailing market prices at the time of sale;

•prices related to such prevailing market prices;

•varying prices determined at the time of sale; or

•negotiated prices.

These sales may be effected in one or more transactions:

•on any national securities exchange or quotation service on which the Shares may be listed or quoted at the time of sale, including the Nasdaq Global Select Market;

•in the over-the-counter market;

•in transactions otherwise than on such exchanges or services or in the over-the-counter market;

•any other method permitted by applicable law; or

•through any combination of the foregoing.

These transactions may include block transactions or crosses. Crosses are transactions in which the same broker acts as an agent on both sides of the trade.

At the time a particular offering of the Shares is made, a prospectus supplement, if required, will be distributed, which will set forth the name of the Selling Stockholders, the aggregate amount of Shares being offered and the terms of the offering, including, to the extent required, (1) the name or names of any underwriters, broker-dealers or

16

agents, (2) any discounts, commissions and other terms constituting compensation from the Selling Stockholders and (3) any discounts, commissions or concessions allowed or reallowed to be paid to broker-dealers.

The Selling Stockholders will act independently of us in making decisions with respect to the timing, manner, and size of each resale or other transfer. There can be no assurance that the Selling Stockholders will sell any or all of the Shares under this prospectus. Further, we cannot assure you that the Selling Stockholders will not transfer, distribute, devise or gift the Shares by other means not described in this prospectus. In addition, any Shares covered by this prospectus that qualify for sale under Rule 144 of the Securities Act may be sold under Rule 144 rather than under this prospectus. The Shares may be sold in some states only through registered or licensed brokers or dealers. In addition, in some states the Shares may not be sold unless they have been registered or qualified for sale or an exemption from registration or qualification is available and complied with.

The Selling Stockholders and any other person participating in the sale of the Shares will be subject to the Exchange Act. The Exchange Act rules include, without limitation, Regulation M, which may limit the timing of purchases and sales of any of the Shares by the Selling Stockholders and any other person. In addition, Regulation M may restrict the ability of any person engaged in the distribution of the Shares to engage in market-making activities with respect to the particular Shares being distributed. This may affect the marketability of the Shares and the ability of any person or entity to engage in market-making activities with respect to the Shares.

The Selling Stockholders may indemnify any broker or underwriter that participates in transactions involving the sale of the Shares against certain liabilities, including liabilities arising under the Securities Act.

17

LEGAL MATTERS

The validity of the shares of Class A common stock offered hereby has been passed upon by Cravath, Swaine & Moore LLP.

EXPERTS

The consolidated financial statements of Robinhood Markets, Inc. appearing in Robinhood Markets, Inc.’s Registration Statement (Form S-1) for the years ended December 31, 2020 and 2019 have been audited by Ernst & Young LLP, independent registered public accounting firm, as set forth in their report thereon, included therein, and incorporated herein by reference. Such consolidated financial statements are incorporated herein by reference in reliance upon such report given on the authority of such firm as experts in accounting and auditing.

18

INFORMATION INCORPORATED BY REFERENCE

The following documents filed with the SEC are hereby incorporated by reference in this prospectus:

•Amendment No. 2 to the Registrant’s Registration Statement on Form S-1 filed with the SEC on July 27, 2021 (File No. 333-257602), which contains the Registrant’s audited financial statements for the latest fiscal year for which such statements have been filed.

•The Registrant’s Prospectus to be filed on or about July 30, 2021 pursuant to Rule 424(b) under the Securities Act, relating to the Registration Statement on Form S-1, as amended (File No. 333-257602).

•The description of the Registrant’s Class A common stock which is contained in a Registration Statement on Form 8-A filed on July 29, 2021 (File No. 001-40691) under the Exchange Act, including any amendment or report filed for the purpose of updating such description.

All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement.

Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

19

WHERE YOU CAN FIND MORE INFORMATION

We file annual, quarterly and other reports, proxy statements and other information with the SEC. Our SEC filings are available to the public over the Internet at the SEC’s website at http://www.sec.gov. Our Annual Report on Form 10-K, Quarterly Reports on Form 10-Q and Current Reports on Form 8-K, including any amendments to those reports, and other information that we file with or furnish to the SEC pursuant to Section 13(a) or 15(d) of the Exchange Act can also be accessed free of charge by linking directly from our website at http://www.robinhood.com. These filings will be available as soon as reasonably practicable after we electronically file such material with, or furnish it to, the SEC. Information contained on our website is not part of this prospectus.

The Registrant hereby undertakes to provide without charge to each person, including any beneficial owner, to whom a copy of this prospectus is delivered, upon written or oral request of any such person, a copy of any and all of the information that has been incorporated by reference in this prospectus but not delivered with the prospectus other than the exhibits to those documents, unless the exhibits are specifically incorporated by reference into the information that this prospectus incorporates. Requests for documents should be directed to Robinhood Markets, Inc. Attention: Corporate Secretary, 85 Willow Road, Menlo Park, California 94025, (844) 428-5411. 

20

PART I

INFORMATION REQUIRED IN THE SECTION 10(A) PROSPECTUS

Item 1.    Plan Information.*

Item 2.    Registration Information and Employee Plan Annual Information.*

* Information required by Part I to be contained in the Section 10(a) prospectus is omitted from this Registration Statement in accordance with Rule 428 under the Securities Act and the “Note” to Part I of Form S-8.

I-1

PART II

INFORMATION REQUIRED IN REGISTRATION STATEMENT

Item 3. Incorporation of Documents by Reference.

The Registrant hereby incorporates by reference into this Registration Statement the following documents previously filed with the SEC :

(1) Amendment No. 2 to the Registrant’s Registration Statement on Form S-1 filed with the SEC on July 27, 2021 (File No. 333-257602), which contains the Registrant’s audited financial statements for the latest fiscal year for which such statements have been filed;

(2) The Registrant’s prospectus to be filed on or about July 30, 2021 pursuant to Rule 424(b) under the Securities Act, relating to the Registrant’s Registration Statement on Form S-1, as amended (File No. 333-257602); and

(3) The description of the Registrant’s Class A common stock contained in the Registrant’s Registration Statement on Form 8-A (File No. 001-40691) filed with the SEC on July 29, 2021, pursuant to Section 12(b) under the Exchange Act of 1934, including any amendment or report filed for the purpose of updating such description.

All documents filed by the Registrant pursuant to Sections 13(a), 13(c), 14 and 15(d) of the Exchange Act on or after the date of this Registration Statement and prior to the filing of a post-effective amendment to this Registration Statement that indicates that all securities offered have been sold or that deregisters all securities then remaining unsold shall be deemed to be incorporated by reference in this Registration Statement and to be part hereof from the date of filing of such documents; provided, however, that documents or information deemed to have been furnished and not filed in accordance with the rules of the SEC shall not be deemed incorporated by reference into this Registration Statement. Any statement contained in a document incorporated or deemed to be incorporated by reference herein shall be deemed to be modified or superseded for purposes of this Registration Statement to the extent that a statement contained herein or in any subsequently filed document which also is deemed to be incorporated by reference herein modifies or supersedes such statement. Any such statement so modified or superseded shall not be deemed, except as so modified or superseded, to constitute a part of this Registration Statement.

Item 4. Description of Securities.

Not applicable.

Item 5. Interests of Named Experts and Counsel.

The legality of the Class A common stock to be offered by the Selling Stockholders has been passed upon by Cravath, Swaine & Moore LLP.

Item 6. Indemnification of Directors and Officers.

The Registrant has entered into indemnification agreements with each of its current directors and executive officers. These agreements require the Registrant to indemnify these individuals to the fullest extent permitted under Delaware law against liabilities that may arise by reason of their service to the Registrant, and to advance expenses incurred as a result of any proceeding against them as to which they could be indemnified. In addition, the indemnification agreements that the Registrant has entered into with Jan Hammer, who is a director of the Registrant and a Partner at Index Ventures, and Scott Sandell, who is a director of the Registrant and a Managing General Partner at New Enterprise Associates, also provide that, among other things, Index Ventures and New Enterprise Associates and their respective affiliates, respectively, will also be entitled to indemnification by the Registrant to the same extent as such director with respect to any claims that are based on such director’s service to us. The Registrant also intends to enter into indemnification agreements with its future directors and executive officers.

Section 145 of the Delaware General Corporation Law (the “DGCL”) provides that a corporation may indemnify directors and officers as well as other employees and individuals against expenses (including attorneys’ fees),

II-2

judgments, fines and amounts paid in settlement actually and reasonably incurred by such person in connection with any threatened, pending or completed actions, suits or proceedings in which such person is made a party by reason of such person being or having been a director, officer, employee or agent to the corporation. The DGCL provides that Section 145 is not exclusive of other rights to which those seeking indemnification may be entitled under any bylaw, agreement, vote of stockholders or disinterested directors or otherwise. The Registrant’s Bylaws provide for indemnification by the Registrant of its directors, officers and employees to the fullest extent permitted by the DGCL.

Section 102(b)(7) of the DGCL permits a corporation to provide in its certificate of incorporation that a director of the corporation shall not be personally liable to the corporation or its stockholders for monetary damages for breach of fiduciary duty as a director, except for liability (i) for any breach of the director’s duty of loyalty to the corporation or its stockholders, (ii) for acts or omissions not in good faith or which involve intentional misconduct or a knowing violation of law, (iii) for unlawful payments of dividends or unlawful stock repurchases, redemptions or other distributions, or (iv) for any transaction from which the director derived an improper personal benefit. The Registrant’s Charter provides for such limitation of liability.

The Registrant maintains standard policies of insurance under which coverage is provided (a) to the Registrant’s directors and officers against loss arising from claims made by reason of breach of duty or other wrongful act, and (b) to the Registrant with respect to payments it may make to its officers and directors pursuant to the above indemnification provision or otherwise as a matter of law.

Item 7. Exemption from Registration Claimed.

The issuance of the Shares being offered by the Form S-8 resale prospectus were deemed to be exempt from registration under the Securities Act in reliance upon Section 4(a)(2) of the Securities Act (or Regulation D or Regulation S promulgated thereunder), or Rule 701 promulgated under Section 3(b) of the Securities Act as transactions by an issuer not involving any public offering or pursuant to benefit plans and contracts relating to compensation as provided under Rule 701. The recipients of the securities in each of these transactions represented their intentions to acquire the securities for investment only and not with a view to or for sale in connection with any distribution thereof, and appropriate legends were placed upon the stock certificates issued in these transactions. All recipients had adequate access, through their relationships with us, to information about the Registrant.

II-3

Item 8. Exhibits.

EXHIBIT INDEX

			Incorporated by Reference
Exhibit Number	Exhibit Description	Form	File No.	Exhibit	Filing Date
4.1	Form of Amended and Restated Certificate of Incorporation of Robinhood Markets, Inc., to be effective immediately prior to the completion of the Registrant’s initial public offering	S-1/A	333-257602	3.1	July 27, 2021
4.3	Form of Amended and Restated Bylaws of Robinhood Markets, Inc., to be effective immediately prior to the completion of the Registrant’s initial public offering	S-1/A	333-257602	3.2	July 27, 2021
4.5	Form of Class A Common Stock Certificate of Robinhood Markets, Inc.	S-1/A	333-257602	4.1	July 27, 2021
5.1*	Opinion of Cravath, Swaine & Moore LLP
23.1*	Consent of Ernst & Young LLP
23.2*	Consent of Cravath, Swaine & Moore LLP (contained in its opinion filed as Exhibit 5.1 hereto)
24.1*	Powers of attorney (included on the signature page hereto)
99.1	Robinhood Markets, Inc. 2020 Equity Incentive Plan, as amended on June 18, 2020, and form grant notices and award agreements thereunder	S-1/A	333-257602	10.3	July 27, 2021
99.2	Robinhood Markets, Inc. Amended and Restated 2013 Stock Plan and form grant notices and award agreements thereunder	S-1/A	333-257602	10.4	July 27, 2021
99.3	Second Amendment to the Robinhood Markets, Inc. 2020 Equity Incentive Plan, dated March 10, 2021	S-1/A	333-257602	10.5	July 27, 2021
99.4	Third Amendment to the Robinhood Markets, Inc. 2020 Equity Incentive Plan, dated May 26, 2021	S-1/A	333-257602	10.6	July 27, 2021
99.5*	Robinhood Markets Inc. Restricted Stock Award Agreement, dated as of July 29, 2020, by and between the Company and Mitchell Burbick

_______________

*Filed herewith.

Item 9.    Undertakings.

A.    The undersigned Registrant hereby undertakes:

(1)    To file, during any period in which offers or sales are being made, a post-effective amendment to this Registration Statement:

(i)    To include any prospectus required by Section 10(a)(3) of the Securities Act;

II-4

(ii)    To reflect in the prospectus any facts or events arising after the effective date of the Registration Statement (or the most recent post-effective amendment thereof) which, individually or in the aggregate, represent a fundamental change in the information set forth in the Registration Statement. Notwithstanding the foregoing, any increase or decrease in volume of securities offered (if the total dollar value of securities offered would not exceed that which was registered) and any deviation from the low or high end of the estimated maximum offering range may be reflected in the form of prospectus filed with the Commission pursuant to Rule 424(b) if, in the aggregate, the changes in volume and price represent no more than a 20 percent change in the maximum aggregate offering price set forth in the “Calculation of Registration Fee” table in the effective Registration Statement; and

(iii)    To include any material information with respect to the plan of distribution not previously disclosed in the Registration Statement or any material change to such information in the Registration Statement.

Provided, however, that paragraphs (A)(1)(i) and (A)(1)(ii) do not apply if the information required to be included in a post-effective amendment by those paragraphs is contained in reports filed with or furnished to the Commission by the Registrant pursuant to Section 13 or Section 15(d) of the Exchange Act that are incorporated by reference in this Registration Statement.

(2)    For the purpose of determining any liability under the Securities Act, each such post-effective amendment shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

(3)    It will remove from registration by means of a post-effective amendment any of the securities being registered which remain unsold at the termination of the offering.

B.    The undersigned Registrant hereby undertakes that, for purposes of determining any liability under the Securities Act, each filing of the Registrant’s annual report pursuant to Section 13(a) or Section 15(d) of the Exchange Act (and, where applicable, each filing of an employee benefit plan’s annual report pursuant to Section 15(d) of the Exchange Act) that is incorporated by reference in the Registration Statement shall be deemed to be a new registration statement relating to the securities offered therein, and the offering of such securities at that time shall be deemed to be the initial bona fide offering thereof.

C.    Insofar as indemnification for liabilities arising under the Securities Act may be permitted to directors, officers and controlling persons of the Registrant pursuant to the foregoing provisions, or otherwise, the Registrant has been advised that in the opinion of the Commission such indemnification is against public policy as expressed in the Securities Act and is, therefore, unenforceable. In the event that a claim for indemnification against such liabilities (other than the payment by the Registrant of expenses incurred or paid by a director, officer or controlling person of the Registrant in the successful defense of any action, suit or proceeding) is asserted by such director, officer or controlling person in connection with the securities being registered, the Registrant will, unless in the opinion of its counsel the matter has been settled by controlling precedent, submit to a court of appropriate jurisdiction the question whether such indemnification by it is against public policy as expressed in the Securities Act and will be governed by the final adjudication of such issue.

II-5

SIGNATURES

Pursuant to the requirements of the Securities Act, the Registrant certifies that it has reasonable grounds to believe that it meets all of the requirements for filing on Form S-8 and has duly caused this Registration Statement to be signed on its behalf by the undersigned, thereunto duly authorized in the City of Menlo Park, State of California, on the 29th day of July, 2021.

ROBINHOOD MARKETS, INC.
By:	/s/Vladimir Tenev
	Vladimir Tenev Co-Founder, Chief Executive Officer and President

POWERS OF ATTORNEY

KNOW ALL PERSONS BY THESE PRESENTS, that each person whose signature appears below constitutes and appoints Daniel Gallagher, Vladimir Tenev and Jason Warnick, and each one of them, as their true and lawful attorneys-in-fact and agents, with full power of substitution and resubstitution, for them and in their name, place and stead, in any and all capacities, to sign any and all amendments (including post-effective amendments) to this Registration Statement on Form S-8, and to file the same, with all exhibits thereto and other documents in connection therewith, with the Securities and Exchange Commission, granting unto said attorneys-in-fact and agents, and each of them, full power and authority to do and perform each and every act and thing requisite and necessary to be done in connection therewith, as fully to all intents and purposes as they might or could do in person, hereby ratifying and confirming all that said attorneys-in-fact and agents or any of them, or their substitute or substitutes, may lawfully do or cause to be done by virtue hereof.

Pursuant to the requirements of the Securities Act, this Registration Statement on Form S-8 has been signed by the following persons in the capacities and on the dates indicated.

Signature	Title	Date
/s/Vladimir Tenev	Co-Founder, Chief Executive Officer, President and Director (Principal Executive Officer)	July 29, 2021
Vladimir Tenev
/s/Jason Warnick	Chief Financial Officer (Principal Financial Officer) (Principal Accounting Officer)	July 29, 2021
Jason Warnick
/s/Baiju Bhatt	Co-Founder, Chief Creative Officer and Director	July 29, 2021
Baiju Bhatt
/s/Jan Hammer	Director	July 29, 2021
Jan Hammer
/s/Paula Loop	Director	July 29, 2021
Paula Loop
/s/Jonathan Rubinstein	Director	July 29, 2021
Jonathan Rubinstein
/s/Scott Sandell	Director	July 29, 2021
Scott Sandell
/s/Robert Zoellick	Director	July 29, 2021
Robert Zoellick

1

EX-5.1

Exhibit 5.1

July 29, 2021

Robinhood Markets, Inc.

Registration Statement on Form S-8

Ladies and Gentlemen:

We have acted as counsel for Robinhood Markets, Inc., a Delaware corporation (the “Company”), in connection with the registration statement on Form S-8 (the “Registration Statement”), filed by the Company with the Securities and Exchange Commission (the “Commission”) under the Securities Act of 1933, as amended (the “Securities Act”) related to the resale from time to time by certain selling stockholders (the “Selling Stockholders”) of up to 42,460,804 shares (the “Resale Shares”) of the Company’s class A common stock, par value $0.0001 per share, issued to the Selling Stockholders by the Company pursuant to the Company’s 2020 Equity Incentive Plan (the “2020 Plan”), Amended and Restated 2013 Stock Plan or a certain Restricted Stock Award Agreement (together with the “2013 Plan” and the 2020 Plan, the “Plans”).

In that connection, we have examined originals, or copies certified or otherwise identified to our satisfaction, of such documents, corporate records and other instruments as we have deemed necessary or appropriate for the purposes of this opinion, including, without limitation: (a) the Amended and Restated Certificate of Incorporation of the Company, as amended; (b) the Amended and Restated By-laws of the Company, as amended; (c) certain resolutions adopted by the Board of Directors of the Company; and (d) the Plans.

In rendering our opinion, we have assumed the genuineness of all signatures, the legal capacity and competency of all natural persons, the authenticity of all documents submitted to us as originals and the conformity to authentic original documents of all documents submitted to us as duplicates or copies. As to all questions of fact material to this opinion that have not been independently established, we have relied upon certificates or comparable documents of officers and representatives of the Company.

2

Based on the foregoing and in reliance thereon, and subject to compliance with applicable state securities laws, we are of the opinion that the Resale Shares are validly issued, fully paid and non-assessable.

We are admitted to practice in the State of New York, and we express no opinion as to matters governed by any laws other than the General Corporation Law of the State of Delaware and the Federal laws of the United States of America.

We hereby consent to the filing of this opinion with the Commission as Exhibit 5.1 to the Registration Statement. In giving this consent, we do not hereby admit that we are within the category of persons whose consent is required under Section 7 of the Securities Act or the rules and regulations of the Commission promulgated thereunder.

	Very truly yours,
	/s/ Cravath, Swaine & Moore LLP
Robinhood Markets, Inc. 85 Willow Road Menlo Park, California 94025
O

EX-23.1

Exhibit 23.1

Consent of Independent Registered Public Accounting Firm

We consent to the reference to our firm under the caption "Experts" in the Registration Statement (Form S-8) and the related reoffer prospectus pertaining to the 2020 Equity Incentive Plan, Amended and Restated 2013 Stock Plan, and Restricted Stock Award Agreement of Robinhood Markets, Inc. and to the incorporation by reference therein of our report dated March 22, 2021, with respect to the consolidated financial statements of Robinhood Markets, Inc., included in the Registration Statement (Form S-1 No. 333-257602) and related Prospectus of Robinhood Markets, Inc. filed with the Securities and Exchange Commission.

San Jose, California

July 29, 2021

EX-99.5

Exhibit 99.5

ROBINHOOD MARKETS, INC.

RESTRICTED STOCK AWARD AGREEMENT

(NON-PLAN AWARD)

This Restricted Stock Award Agreement (the “Agreement”) is made and entered into as of July 29, 2020 (the “Effective Date”) by and between Robinhood Markets, Inc., a Delaware corporation (the “Company”), and Mitchell Burbick (“Awardee”).

1.AWARD OF SHARES. On the Effective Date and subject to the terms and conditions of this Agreement, the Company hereby awards Awardee 6,000 shares of the Company’s Common Stock (the “Shares”) for no consideration. As used in this Agreement, the term “Shares” includes the Shares awarded under this Agreement and all securities received (a) in replacement of the Shares, (b) as a result of stock dividends or stock splits with respect to the Shares, and (c) in replacement of the Shares in a merger, recapitalization, reorganization or similar corporate transaction.

2.DELIVERIES.

2.1.Deliveries by the Awardee. Awardee hereby delivers to the Company: (a) this completed and signed Agreement; (b) one copy of a blank Stock Power and Assignment Separate from Stock Certificate in the form of Exhibit 1 attached hereto, executed by Awardee (and Awardee’s spouse, if any); and (c) if Awardee is married, a Consent of Spouse in the form of Exhibit 2 attached hereto.

2.2.Deliveries by the Company. Upon its receipt of all the documents to be executed and delivered by Awardee to the Company as provided herein, the Company will issue a duly executed electronic stock certificate evidencing the Shares in the name of Awardee with the appropriate legends affixed thereto. The electronic stock certificate will be placed in escrow as provided in Section 6.2 to secure performance of Awardee’s obligations under Section 5 until expiration or termination of the Company’s Refusal Right (as such terms are defined in Section 5).

3.REPRESENTATIONS AND WARRANTIES OF AWARDEE. Awardee represents and warrants to the Company as follows.

3.1.Acknowledgment of Tax Risks. Awardee acknowledges that there may be adverse tax consequences upon the acquisition and the disposition of the Shares, and that Awardee has been advised by the Company to consult a tax adviser prior to such acquisition or disposition. Awardee further acknowledges that Awardee is not relying on the Company or its counsel for tax advice regarding Awardee’s disposition of the Shares or the tax consequences to Awardee of this Agreement. Awardee understands that Awardee shall be responsible for any tax liability that may arise as a result of the transactions contemplated by this Agreement, including United States federal, state, local and foreign income, withholding, payroll, employment, social security, and unemployment taxes (including any interest and penalties) arising as a result of the award of the Shares to Awardee pursuant to this Agreement.

3.2.Shares Not Registered or Qualified. Awardee understands and acknowledges that the Shares have not been registered with the Securities Exchange Commission (the “SEC”) under the Securities Act of 1933, as amended (the “Securities Act”), or with any securities regulatory agency administering any state securities laws, and that, notwithstanding any other provision of this Agreement to the contrary, the acquisition of any Shares is expressly conditioned upon compliance with the Securities Act and all applicable state securities laws. Awardee agrees to cooperate with the Company to ensure compliance with such laws.

3.3.No Transfer Unless Registered or Exempt; Contractual Restrictions on Transfers. Awardee understands that Awardee may not transfer any Shares unless such Shares are registered under the Securities Act or qualified under applicable state securities laws or unless, in the opinion of counsel to the Company, exemptions from such registration and qualification requirements are available. Awardee understands that only the Company may file a registration statement with the SEC and that the Company is under no obligation to do so with respect to the Shares. Awardee has also been advised that exemptions from registration and qualification may not be available or may not permit Awardee to transfer all or any of the Shares in the amounts or at the times proposed by Awardee. Awardee further acknowledges that this Agreement imposes additional restrictions on transfer of the Shares. In addition, Awardee acknowledges and agrees that the Shares shall be subject to the restrictions on transferability and resale set forth in the Company’s Bylaws, as amended (the “Bylaws”).

3.4.Understanding of Risks. Awardee is fully aware of: (a) the highly speculative nature of the investment in the Shares; (b) the financial hazards involved; (c) the lack of liquidity of the Shares and the restrictions on transferability of the Shares (e.g., that Awardee may not be able to sell or dispose of the Shares or use them as collateral for loans); (d) the qualifications and backgrounds of the management of the Company; and (e) the tax consequences of investment in, and disposition of, the Shares.

3.5.Acquisition for Own Account for Investment. Awardee is acquiring the Shares for Awardee’s own account for investment purposes only and not with a view to, or for sale in connection with, a distribution of the Shares within the meaning of the Securities Act. Awardee has no present intention of selling or otherwise disposing of all or any portion of the Shares and no one other than Awardee has any beneficial ownership of any of the Shares.

3.6.No General Solicitation. At no time was Awardee presented with or solicited by any publicly issued or circulated newspaper, mail, radio, television or other form of general advertising or solicitation in connection with the award of the Shares.

3.7.SEC Rule 144. Awardee has been advised that SEC Rule 144 promulgated under the Securities Act, which permits certain limited sales of unregistered securities, is not presently available with respect to the Shares and, in any event, requires that the Shares be held for a minimum of six (6) months, and in certain cases one (1) year, after they have been purchased and paid for (within the meaning of Rule 144), subject to the lengthier Market Standoff agreement contained in Section 4 of this Agreement or any other agreement entered into by Awardee. Awardee understands that Rule 144 may indefinitely restrict transfer of the Shares

2

so long as Awardee remains an “affiliate” of the Company or if “current public information” about the Company (as defined in Rule 144) is not publicly available.

4.MARKET STANDOFF AGREEMENT. Awardee hereby agrees that it will not, without the prior written consent of the managing underwriter, during the period commencing on the date of the final prospectus relating to the registration by the Company of shares of its Common Stock or any other equity securities under the Securities Act on a registration statement on Form S-1 or Form S-3 (the “IPO”), and ending on the date specified by the Company and the managing underwriter (such period not to exceed one hundred eighty (180) days): (a) lend, offer, pledge, sell, contract to sell, sell any option or contract to purchase, purchase any option or contract to sell, grant any option, right, or warrant to purchase, or otherwise transfer or dispose of, directly or indirectly, any shares of Common Stock or any securities convertible into or exercisable or exchangeable (directly or indirectly) for Common Stock held immediately before the effective date of the registration statement for the IPO; or (b) engage in any hedging or other transaction or arrangement (including, without limitation, any short sale or the purchase or sale of, or entry into, any put or call option, or combination thereof, forward, swap or any other derivative transaction or instrument, however described or defined) which is designed to effect a sale or disposition, or transfer of any of the economic consequences of ownership, in whole or in part, directly or indirectly, of any shares of Common Stock or any securities or rights convertible into, or exercisable or exchangeable for (in each case, directly or indirectly), Common Stock, including options and warrants, held immediately before the effective date of the registration statement for the IPO, whether any such transaction described in clause (a) or (b) above is to be settled by delivery of Common Stock or other securities, in cash, or otherwise (the “Market Standoff”). The foregoing provisions of this Section 4 shall apply only to the IPO (if the Company has not already completed a direct listing) and shall not apply to a direct listing or to the sale of any shares to an underwriter pursuant to an underwriting agreement, or the transfer of any shares to any trust for the direct or indirect benefit of Awardee or the immediate family of Awardee, provided, that the trustee of the trust agrees to be bound in writing by the restrictions set forth herein, and provided, further, that any such transfer shall not involve a disposition for value. The underwriters in connection with such registration are intended third-party beneficiaries of this Section 4 and shall have the right, power and authority to enforce the provisions hereof as though they were a party hereto. Awardee further agrees to execute such agreements as may be reasonably requested by the underwriters in connection with such registration that are consistent with this Section 4 or that are necessary to give further effect thereto.

5.COMPANY’S REFUSAL RIGHT. Before any Shares held by Awardee or any transferee of such Shares (either sometimes referred to herein as the “Holder”) may be sold or otherwise transferred (including, without limitation, a transfer by gift or operation of law), the Company and/or its assignee(s) will have a right of first refusal to purchase the Shares to be sold or transferred (the “Offered Shares”) on the terms and conditions set forth in this Section (the “Refusal Right”).

5.1.Notice of Proposed Transfer. The Holder of the Offered Shares will deliver to the Company a written notice (the “Notice”) stating: (a) the Holder’s bona fide

3

intention to sell or otherwise transfer the Offered Shares; (b) the name and address of each proposed purchaser or other transferee of Offered Shares (“Proposed Transferee”); (c) the number of Offered Shares to be transferred to each Proposed Transferee; (d) the bona fide cash price or other consideration for which the Holder proposes to transfer the Offered Shares to each Proposed Transferee (the “Offered Price”); and (e) that the Holder acknowledges this Notice is an offer to sell the Offered Shares to the Company and/or its assignee(s) pursuant to the Company’s Refusal Right at the Offered Price as provided for in this Agreement.

5.2.Exercise of Refusal Right. At any time within thirty (30) days after the date the Notice is effective pursuant to Section 7.2, the Company and/or its assignee(s) may, by giving written notice to the Holder, elect to purchase all (or, with the consent of the Holder, less than all) the Offered Shares proposed to be transferred to any one or more of the Proposed Transferees named in the Notice, at the purchase price, determined as provided in Section 5.3 below.

5.3.Purchase Price. The purchase price for the Offered Shares purchased under this Section will be the Offered Price, providedthat if the Offered Price consists of no legal consideration (as, for example, in the case of a transfer by gift), then the purchase price will be the fair market value of the Offered Shares as determined in good faith by the Company’s Board of Directors. If the Offered Price includes consideration other than cash, then the value of the non-cash consideration, as determined in good faith by the Company’s Board of Directors, will conclusively be deemed to be the cash equivalent value of such non-cash consideration.

5.4.Payment. The purchase price for the Offered Shares will be paid, at the option of the Company and/or its assignee(s) (as applicable), by cash (check, ACH transfer or wire transfer) or by cancellation of all or a portion of any outstanding indebtedness owed by the Holder to the Company (or to such assignee, in the case of a purchase of Offered Shares by such assignee) or by any combination thereof. The purchase price will be paid without interest within sixty (60) days after the Company’s receipt of the Notice, or, at the option of the Company and/or its assignee(s), in the manner and at the time(s) set forth in the Notice.

5.5.Holder’s Right to Transfer. If all of the Offered Shares proposed in the Notice to be transferred to a given Proposed Transferee are not purchased by the Company and/or its assignee(s) as provided in this Section, then the Holder may sell or otherwise transfer such Offered Shares to such Proposed Transferee at the Offered Price or at a higher price, providedthat (a) such sale or other transfer is consummated within one hundred twenty (120) days after the date the Notice is effective pursuant to Section 7.2, (b) any such sale or other transfer is effected in compliance with all applicable securities laws, and (c) such Proposed Transferee agrees in writing that the provisions of this Section will continue to apply to the Offered Shares in the hands of such Proposed Transferee. If the Offered Shares described in the Notice are not transferred to such Proposed Transferee within such one hundred twenty (120) day period, then a new Notice must be given to the Company pursuant to which the Company will again be offered the Refusal Right before any Shares held by the Holder may be sold or otherwise transferred.

4

5.6.Exempt Transfers. Notwithstanding the foregoing, the following transfers of Shares will be exempt from the Refusal Right: (a) the transfer of any or all of the Shares during Awardee’s lifetime by gift or on Awardee’s death by will or intestacy to Awardee’s “Immediate Family” (as defined below) or to a trust for the benefit of Awardee or Awardee’s Immediate Family, providedthat each transferee agrees in a writing satisfactory to the Company that the provisions of this Section will continue to apply to the transferred Shares in the hands of such transferee; (b) any transfer of Shares made pursuant to a statutory merger or statutory consolidation of the Company with or into another entity or entities (except that, subject to Section 5.7, unless the agreement of merger or consolidation expressly otherwise provides, the Refusal Right will continue to apply thereafter to such Shares, in which case the surviving entity of such merger or consolidation shall succeed to the rights of the Company under this Section); or (c) any transfer of Shares pursuant to the winding up and dissolution of the Company. As used herein, the term “Immediate Family” will mean Awardee’s spouse, the lineal descendant or antecedent, father, mother, brother or sister, child, adopted child, grandchild or adopted grandchild of Awardee or Awardee’s spouse, or the spouse of any of the above or Spousal Equivalent, as defined herein. As used herein, a person is deemed to be a “Spousal Equivalent” provided the following circumstances are true: (i) irrespective of whether or not the Awardee and the Spousal Equivalent are the same sex, they are the sole spousal equivalent of the other for the last twelve (12) months, (ii) they intend to remain so indefinitely, (iii) neither are married to anyone else, (iv) both are at least 18 years of age and mentally competent to consent to contract, (v) they are not related by blood to a degree of closeness that which would prohibit legal marriage in the state in which they legally reside, (vi) they are jointly responsible for each other’s common welfare and financial obligations, and (vii) they reside together in the same residence for the last twelve (12) months and intend to do so indefinitely.

5.7.Termination of Refusal Right. The Refusal Right will terminate as to all Shares: (a) on the effective date of the first sale of Common Stock of the Company to the public pursuant to a registration statement filed with and declared effective by the SEC under the Securities Act or, if expressly approved by the Board as terminating the Refusal Right, under the laws of any other country having substantially the same effect (other than a registration statement relating solely to the issuance of Common Stock pursuant to a business combination or an employee incentive or benefit plan) or (b) on any transfer or conversion of Shares made pursuant to a statutory merger or statutory consolidation of the Company with or into another entity or entities if the common stock of the surviving entity or any direct or indirect parent entity thereof is registered under the Securities Exchange Act of 1934, as amended.

6.ADDITIONAL RESTRICTIONS UPON SHARE OWNERSHIP OR TRANSFER.

6.1.Rights as a Stockholder. Subject to the terms and conditions of this Agreement, Awardee will have all of the rights of a Stockholder of the Company with respect to the Shares from and after the date that Shares are issued to Awardee until such time as Awardee disposes of the Shares or the Company and/or its assignee(s) exercise(s) the Refusal Right. Upon an exercise of the Refusal Right, Awardee will have no further rights as a holder of the Shares so purchased upon such exercise, other than the right to receive payment for the Shares so

5

purchased in accordance with the provisions of this Agreement, and Awardee will promptly surrender the stock certificate(s) evidencing the Shares so purchased to the Company for transfer or cancellation.

6.2.Escrow. As security for Awardee’s faithful performance of this Agreement, Awardee agrees, immediately upon receipt of the stock certificate(s) evidencing the Shares via welcome@carta.com, to surrender such certificate(s) to the Secretary of the Company or other designee of the Company (the “Escrow Holder”), who is hereby appointed to hold such certificate(s) in escrow and to take all such actions and to effectuate all such transfers and/or releases of such Shares as are in accordance with the terms of this Agreement. Awardee and the Company agree that Escrow Holder will not be liable to any party to this Agreement (or to any other person or entity) for any actions or omissions unless Escrow Holder is grossly negligent or intentionally fraudulent in carrying out the duties of Escrow Holder under this Agreement. Escrow Holder may rely upon any letter, notice or other document executed with any signature purported to be genuine and may rely on the advice of counsel and obey any order of any court with respect to the transactions contemplated by this Agreement. The Shares will be released from escrow upon termination of the restrictions applicable to the Shares, including, without limitation, the transfer restrictions set forth in the Bylaws, the Market Standoff and the Refusal Right.

6.3.Encumbrances on Shares. Without the Company’s prior written consent given with the approval of the Company’s Board of Directors, Awardee may not grant a lien or security interest in, or pledge, hypothecate or encumber, any Shares.

6.4.Restrictions on Transfers. Pursuant to the restrictions set forth in the Bylaws, the Shares may not be sold or otherwise transferred by Awardee without the Company’s prior written consent. Subject to obtaining such consent, Awardee hereby agrees that Awardee shall make no disposition of the Shares (other than as permitted by this Agreement) unless and until:

(a)Awardee shall have notified the Company of the proposed disposition and provided a written summary of the terms and conditions of the proposed disposition;

(b)Awardee shall have complied with all requirements of this Agreement applicable to the disposition of the Shares, including but not limited to the Refusal Right and the Market Standoff; and

(c)Awardee shall have provided the Company with written assurances, in form and substance satisfactory to counsel for the Company, that (i) the proposed disposition does not require registration of the Shares under the Securities Act or under any state securities laws, and (ii) all appropriate actions necessary for compliance with the registration and qualification requirements of the Securities Act and any state securities laws, or of any exemption from registration or qualification, available thereunder (including Rule 144) have been taken.

6

Each person (other than the Company) to whom the Shares are transferred by means of one of the permitted transfers specified in this Agreement must, as a condition precedent to the validity of such transfer, acknowledge in writing to the Company that such person is bound by the provisions of this Agreement and that the transferred Shares are subject to the Refusal Right and the Market Standoff, to the same extent such Shares would be so subject if retained by the Awardee. In addition, Awardee acknowledges and agrees that the Shares shall be subject to the restrictions on transferability and resale set forth in the Company’s Bylaws.

6.5.Restrictive Legends and Stop-transfer Orders. Awardee understands and agrees that the Company will place the legends set forth below or similar legends on any stock certificate(s) evidencing the Shares, together with any other legends that may be required by applicable laws, the Company’s Certificate of Incorporation or Bylaws, any other agreement between Awardee and the Company or any agreement between Awardee and any third party:

THE SECURITIES REPRESENTED HEREBY HAVE NOT BEEN REGISTERED UNDER THE SECURITIES ACT OF 1933, AS AMENDED (THE “SECURITIES ACT”), OR UNDER THE SECURITIES LAWS OF CERTAIN STATES. THESE SECURITIES ARE SUBJECT TO RESTRICTIONS ON TRANSFERABILITY AND RESALE AND MAY NOT BE TRANSFERRED OR RESOLD EXCEPT AS PERMITTED UNDER THE SECURITIES ACT AND APPLICABLE STATE SECURITIES LAWS, PURSUANT TO REGISTRATION OR EXEMPTION THEREFROM. INVESTORS SHOULD BE AWARE THAT THEY MAY BE REQUIRED TO BEAR THE FINANCIAL RISKS OF THIS INVESTMENT FOR AN INDEFINITE PERIOD OF TIME. THE ISSUER OF THESE SECURITIES MAY REQUIRE AN OPINION OF COUNSEL IN FORM AND SUBSTANCE SATISFACTORY TO THE ISSUER TO THE EFFECT THAT ANY PROPOSED TRANSFER OR RESALE IS IN COMPLIANCE WITH THE SECURITIES ACT AND ANY APPLICABLE STATE SECURITIES LAWS.

THE SHARES REPRESENTED BY THIS CERTIFICATE ARE SUBJECT TO CERTAIN RESTRICTIONS ON PUBLIC RESALE AND TRANSFER, INCLUDING THE RIGHT OF FIRST REFUSAL HELD BY THE ISSUER AND/OR ITS ASSIGNEE(S), AND A MARKET STANDOFF AGREEMENT, AS SET FORTH IN A RESTRICTED STOCK PURCHASE AGREEMENT BETWEEN THE ISSUER AND THE ORIGINAL HOLDER OF THESE SHARES, A COPY OF WHICH MAY BE OBTAINED AT THE PRINCIPAL OFFICE OF THE ISSUER. SUCH PUBLIC SALE AND TRANSFER RESTRICTIONS INCLUDING THE RIGHT OF FIRST REFUSAL AND THE MARKET STANDOFF ARE BINDING ON TRANSFEREES OF THESE SHARES.

THE SHARES REPRESENTED BY THIS CERTIFICATE MAY NOT BE SOLD, ASSIGNED, TRANSFERRED, PLEDGED, ENCUMBERED OR IN ANY MANNER DISPOSED OF, EXCEPT IN COMPLIANCE WITH THE BYLAWS OF THE CORPORATION.

7

COPIES OF THE BYLAWS OF THE CORPORATION MAY BE OBTAINED UPON WRITTEN REQUEST TO THE SECRETARY OF THE CORPORATION.

Awardee also agrees that, to ensure compliance with the restrictions imposed by this Agreement, the Company may issue appropriate “stop-transfer” instructions to its transfer agent, if any, and if the Company transfers its own securities, it may make appropriate notations to the same effect in its own records. The Company will not be required (a) to transfer on its books any Shares that have been sold or otherwise transferred in violation of any of the provisions of this Agreement or the Company’s Bylaws or (b) to treat as owner of such Shares, or to accord the right to vote or pay dividends to any purchaser or other transferee to whom such Shares have been so transferred.

7.GENERAL PROVISIONS.

7.1.Successors and Assigns. The Company may assign any of its rights under this Agreement, including its rights to purchase Shares under the Refusal Right. Neither Awardee, nor any of Awardee’s successors and assigns, may assign, whether voluntarily or by operation of law, any of its rights and obligations under this Agreement, except with the prior written consent of the Company. This Agreement shall be binding upon and inure to the benefit of the successors and assigns of the Company. Subject to the restrictions on transfer herein set forth, this Agreement will be binding upon Awardee and Awardee’s heirs, executors, administrators, legal representatives, successors and assigns.

7.2.Notices. Any and all notices required or permitted to be given to a party pursuant to the provisions of this Agreement will be in writing and will be effective and deemed to provide such party sufficient notice under this Agreement on the earliest of the following: (i) at the time of personal delivery, if delivery is in person; (ii) at the time an electronic confirmation of receipt is received, if delivery is by email; (iii) at the time of transmission by facsimile, addressed to the other party at its facsimile number specified herein (or hereafter modified by subsequent notice to the parties hereto), with confirmation of receipt made by both telephone and printed confirmation sheet verifying successful transmission of the facsimile; (iv) one (1) business day after deposit with an express overnight courier for United States deliveries, or two (2) business days after such deposit for deliveries outside of the United States, with proof of delivery from the courier requested; or (v) three (3) business days after deposit in the United States mail by certified mail (return receipt requested) for United States deliveries. Any notice for delivery outside the United States will be sent by email, facsimile or by express courier. Any notice not delivered personally or by email will be sent with postage and/or other charges prepaid and properly addressed to Awardee at the last known address or facsimile number on the books of the Company, or at such other address or facsimile number as such other party may designate by one of the indicated means of notice herein to the other parties hereto or, in the case of the Company, to it at its principal place of business. Notices to the Company will be marked “Attention: Stock Admin.” Notices by facsimile shall be machine verified as received.

7.3.Further Assurances. The parties agree to execute such further documents and instruments and to take such further actions as may be reasonably necessary to carry out the purposes and intent of this Agreement.

8

7.4.Entire Agreement. This Agreement, together with all Exhibits hereto, constitute the entire agreement and understanding of the parties with respect to the subject matter of this Agreement, and supersede all prior understandings and agreements, between the parties hereto with respect to the specific subject matter hereof.

7.5.Amendment and Waivers. This Agreement may be amended only by a written agreement executed by each of the parties hereto. No amendment of or waiver of, or modification of any obligation under this Agreement will be enforceable unless set forth in a writing signed by the party against which enforcement is sought. Any amendment effected in accordance with this section will be binding upon all parties hereto and each of their respective successors and assigns. No delay or failure to require performance of any provision of this Agreement shall constitute a waiver of that provision as to that or any other instance. No waiver granted under this Agreement as to any one provision herein shall constitute a subsequent waiver of such provision or of any other provision herein, nor shall it constitute the waiver of any performance other than the actual performance specifically waived.

7.6.Severability. If any provision of this Agreement is determined by any court or arbitrator of competent jurisdiction to be invalid, illegal or unenforceable in any respect, such provision will be enforced to the maximum extent possible given the intent of the parties hereto. If such clause or provision cannot be so enforced, such provision shall be stricken from this Agreement and the remainder of this Agreement shall be enforced as if such invalid, illegal or unenforceable clause or provision had (to the extent not enforceable) never been contained in this Agreement. Notwithstanding the forgoing, if the value of this Agreement based upon the substantial benefit of the bargain for any party is materially impaired, which determination as made by the presiding court or arbitrator of competent jurisdiction shall be binding, then both parties agree to substitute such provision(s) through good faith negotiations.

7.7.Execution. This Agreement may be entered into in two or more counterparts, each of which shall be deemed an original and all of which shall constitute one and the same agreement. This Agreement may be executed and delivered by facsimile or other means of electronic delivery and, upon such delivery, the facsimile signature will be deemed to have the same effect as if the original signature had been delivered to the other party.

[Signature Page Follows]

9

IN WITNESS WHEREOF, the Company has caused this Restricted Stock Award Agreement to be executed by its duly authorized representative, and Awardee has executed this Restricted Stock Award Agreement, as of the date first set forth above.

ROBINHOOD MARKETS, INC.		AWARDEE
By:/s/Jason Warnick		/s/Mitchell Burbick
		Mitchell Burbick
Address:	85 Willow Road	Address:	Address
	Menlo Park, CA 94025